###begin article-title 0
###xml 20 27 20 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 102 107 <span type="species:ncbi:9606">Human</span>
Association between TCF7L2 gene polymorphisms and susceptibility to Type 2 Diabetes Mellitus: a large Human Genome Epidemiology (HuGE) review and meta-analysis
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 31 37 31 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2</italic>
###xml 389 396 389 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
Transcription factor 7-like 2 (TCF7L2) has been shown to be associated with type 2 diabetes mellitus (T2MD) in multiple ethnic groups in the past two years, but, contradictory results were reported for Chinese and Pima Indian populations. The authors then performed a large meta-analysis of 36 studies examining the association of type 2 diabetes mellitus (T2DM) with polymorphisms in the TCF7L2 gene in various ethnicities, containing rs7903146 C-to-T (IVS3C>T), rs7901695 T-to-C (IVS3T>C), a rs12255372 G-to-T (IVS4G>T), and rs11196205 G-to-C (IVS4G>C) polymorphisms and to evaluate the size of gene effect and the possible genetic mode of action.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 195 197 195 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
Literature-based searching was conducted to collect data and three methods, that is, fixed-effects, random-effects and Bayesian multivariate mete-analysis, were performed to pool the odds ratio (OR). Publication bias and study-between heterogeneity were also examined.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 138 141 138 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR </italic>
###xml 236 239 236 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CrI</italic>
###xml 268 271 268 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CrI</italic>
###xml 513 516 513 516 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CrI</italic>
###xml 544 547 544 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CrI</italic>
###xml 583 585 583 585 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 857 859 857 859 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 875 877 875 877 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 960 967 960 967 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
The studies included 35,843 cases of T2DM and 39,123 controls, using mainly primary data. For T2DM and IVS3C>T polymorphism, the Bayesian OR for TT homozygotes and TC heterozygotes versus CC homozygote was 1.968 (95% credible interval (CrI): 1.790, 2.157), 1.406 (95% CrI: 1.341, 1.476), respectively, and the population attributable risk (PAR) for the TT/TC genotypes of this variant is 16.9% for overall. For T2DM and IVS4G>T polymorphism, TT homozygotes and TG heterozygotes versus GG homozygote was 1.885 (95%CrI: 1.698, 2.088), 1.360 (95% CrI: 1.291, 1.433), respectively. Four ORs among these two polymorphisms all yielded significant between-study heterogeneity (P < 0.05) and the main source of heterogeneity was ethnic differences. Data also showed significant associations between T2DM and the other two polymorphisms, but with low heterogeneity (P > 0.10). Pooled ORs fit a codominant, multiplicative genetic model for all the four polymorphisms of TCF7L2 gene, and this model was also confirmed in different ethnic populations when stratification of IVS3C>T and IVS4G>T polymorphisms except for Africans, where a dominant, additive genetic mode is suggested for IVS3C>T polymorphism.
###end p 7
###begin title 8
Conclusion
###end title 8
###begin p 9
###xml 54 61 54 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 197 204 197 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 331 338 331 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
This meta-analysis demonstrates that four variants of TCF7L2 gene are all associated with T2DM, and indicates a multiplicative genetic model for all the four polymorphisms, as well as suggests the TCF7L2 gene involved in near 1/5 of all T2MD. Potential gene-gene and gene-environmental interactions by which common variants in the TCF7L2 gene influence the risk of T2MD need further exploration.
###end p 9
###begin title 10
Background
###end title 10
###begin p 11
###xml 216 217 216 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 407 408 407 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 517 518 517 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 664 665 664 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 777 778 777 778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 779 780 779 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 903 904 903 904 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 905 907 905 907 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 932 934 932 934 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 935 937 935 937 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 965 967 965 967 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 994 996 994 996 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 997 999 997 999 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 1033 1035 1033 1035 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 1036 1038 1036 1038 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 1073 1074 1073 1074 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 1075 1077 1075 1077 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 1078 1080 1078 1080 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 1119 1121 1119 1121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 1122 1124 1122 1124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 1268 1270 1268 1270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 1271 1273 1271 1273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 1274 1276 1274 1276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 1372 1374 1372 1374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 1375 1377 1375 1377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 1378 1380 1378 1380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 1381 1383 1381 1383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
Type 2 diabetes mellitus (T2DM) is characterized by hyperglycemia that can occur through mechanisms such as impaired insulin secretion, insulin resistance in peripheral tissues and increased glucose output by liver [1]. Most individuals with T2DM suffer serious complications of chronic hyperglycemia, involved in nephropathy, neuropathy, retinopathy, and accelerated development of cardiovascular disease [2]. The prevalence of T2DM has increased sharply during the past two decades in the world and is close to 6% [3]. But estimations suggest that this trend will continue to rise over the next decade owing to increasing age of population and surge of obesity [4]. Accounting for 90~95% of populations with diabetes, T2DM is projected to 300 million worldwide by year 2025 [2,4], and its incidence exhibits significant geographic and racial difference, ranging from more than 0.3 to 17.9% in Africa [5-11], 1.2 to 14.6% in Asia [12-19], about 2.5% in Australia [20], 0.7 to 11.6% in Europe [21-32], 4.6 to 40% in the Middle East [33-36], 6.69 to 28.2% in North America [3,37-39], and 2.01 to 17.4% in South America [40-43]. Recent years, new diagnosis of T2DM subjects in developing nations with a mass of populations such as China and India has increased rapidly [19,44,45], and it has also found remarkable augmented in rural that being with lower prevalence before [14,17,19,45]. Incidence rates are diverse in females and males in Europe, North America, Africa, Latin America and East Asia, and there are scarcely reports with accordant result.
###end p 11
###begin p 12
###xml 31 37 31 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2</italic>
###xml 96 98 96 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 305 307 305 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 308 310 308 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 449 455 449 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2</italic>
###xml 519 521 519 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 576 583 576 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 665 670 665 670 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLP-1</italic>
###xml 673 675 673 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 676 678 676 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 689 693 689 693 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLP1</italic>
###xml 800 807 800 807 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 892 898 892 898 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLP-1 </italic>
###xml 906 908 906 908 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 445 448 <span type="species:ncbi:9685">cat</span>
###xml 572 575 <span type="species:ncbi:9685">cat</span>
Transcription factor 7-like 2 (TCF7L2) gene spans a 215,863 bases region on chromosome 10q25.3 [46] (114700201-114916063, NCBI build 36.2), and its product is a high-mobility box-containing transcription factor that has a role in activating many genes downstream of the Wnt signaling pathway and in T2DM [47-50]. The mechanisms through which TCF7L2 affects the susceptibility to T2DM remain to be elucidated. The bipartite transcription factor, cat/TCF7L2, activates many genes downstream of the Wnt signaling cascade [51]. One of the genes transcriptionally regulated by cat/TCF7L2 is proglucagon, which encodes the insulinotropic hormone glucagon-like peptide 1 (GLP-1) [49,50]. Because GLP1, in concert with insulin, plays a critical role in blood glucose homeostasis, it has been postulated that TCF7L2 gene variants may affect the susceptibility to type2 diabetes by indirectly altering GLP-1 levels [50].
###end p 12
###begin p 13
###xml 10 17 10 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 104 106 104 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 123 130 123 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 379 380 379 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 381 383 381 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 384 386 384 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 387 389 387 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 491 492 491 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 493 495 493 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 496 498 496 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B55">55</xref>
###xml 601 602 601 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 603 605 603 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B56">56</xref>
###xml 712 714 712 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B57">57</xref>
###xml 715 717 715 717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B58">58</xref>
###xml 815 816 815 816 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 817 819 817 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 820 822 820 822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B59">59</xref>
###xml 823 825 823 825 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B65">65</xref>
###xml 924 925 924 925 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 926 928 926 928 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 929 931 929 931 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B57">57</xref>
###xml 932 934 932 934 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B58">58</xref>
###xml 1097 1099 1097 1099 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B59">59</xref>
###xml 1100 1102 1100 1102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B66">66</xref>
###xml 1121 1122 1121 1122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 1123 1125 1123 1125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 1137 1139 1137 1139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B67">67</xref>
###xml 1140 1142 1140 1142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B68">68</xref>
###xml 1157 1159 1157 1159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B69">69</xref>
###xml 1160 1162 1160 1162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B70">70</xref>
###xml 1202 1204 1202 1204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B57">57</xref>
###xml 1205 1207 1205 1207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B61">61</xref>
###xml 1208 1210 1208 1210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B62">62</xref>
###xml 1211 1213 1211 1213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B71">71</xref>
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human TCF7L2 gene consists of 14 exons and 13 introns (NCBI build 36.2). However, a previous study [52] has shown that TCF7L2 has 17 exons, of which five are alternative. There are at least four well-studied polymorphic markers that have brought the most attention, that is, (1) a C-to-T (genomic position: 114748339) substitution at snp rs7903146 of the intron 3 (IVS3C>T) [2,47,53,54]; (2) a T-to-C (genomic position: 114744078) substitution at snp rs7901695 of the intron 3(IVS3T>C) [2,53,55]; (3) a G-to-T (genomic position: 14798892) substitution at snp rs12255372 of the intron 4 (IVS4G>T) [2,56]; and (4) a G-to-C (genomic position: 114797037)substitution at snp rs11196205 of the intron 4 (IVS4G>C) [57,58]. Most published epidemiologic studies have emphasized on the IVS3C>T and IVS4G>T polymorphisms [2,47,59-65]. There are plenty of evidence on strong linkage disequilibrium between these four polymorphisms [2,47,57,58]. The T allele of the IVS3C>T, C allele of the IVS3T>C, and T allele of IVS4G>T, as well as C allele of IVS4G>C polymorphisms have higher frequency in Caucasian [59,66], North European [2,47], African [67,68], and Indian [69,70] populations than those in East Asian [57,61,62,71] populations.
###end p 13
###begin p 14
###xml 182 187 182 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PPARG</italic>
###xml 189 196 189 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KCNJ11 </italic>
###xml 200 205 200 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CPN10</italic>
###xml 419 421 419 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B72">72</xref>
###xml 471 477 471 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2</italic>
###xml 479 486 479 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC30A8</italic>
###xml 488 492 488 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HHEX</italic>
###xml 494 498 494 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ETX2</italic>
###xml 500 506 500 506 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKN2A</italic>
###xml 507 513 507 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKN2B</italic>
###xml 515 522 515 522 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IGF2BP2</italic>
###xml 524 530 524 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKAL1</italic>
###xml 532 535 532 535 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FTO</italic>
###xml 537 542 537 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PPARG</italic>
###xml 548 555 548 555 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KCNJ11 </italic>
###xml 600 601 600 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 602 604 602 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B73">73</xref>
###xml 605 607 605 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B76">76</xref>
###xml 698 705 698 705 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 896 897 896 897 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 934 941 934 941 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 977 978 977 978 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 1373 1380 1373 1380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
The polygenic basis of T2DM has been intensely investigated by large consortia worldwide, and consensus on a range of valid susceptibility genes has emerged. Such genes, for example PPARG, KCNJ11 and CPN10, appear to contain common variation that confers only 10-20% additional risk of T2DM, and only studies with large numbers of case and controls have had sufficient statistical power to examine their role robustly [72]. Recent years, some novel loci in genes such as TCF7L2, SLC30A8, HHEX, ETX2, CDKN2A/CDKN2B, IGF2BP2, CDKAL1, FTO, PPARG, and KCNJ11 have been found with susceptibility to T2DM [2,73-76], and these has promoted the development of genetics on T2DM. From 2006 to 2008, study on TCF7L2 gene polymorphisms and its association with T2DM has become the focus in diabetes mellitus, therefore, some meaningful results have reported one by one. In March, 2006, Grant and colleagues [2] first proposed an association with TCF7L2 gene variants with T2DM. The study [2] consisted of three samples from Iceland, Denmark and USA with strikingly similar results. Since then, this potential association has been examined in over 50 samples from around the world. Given the amount of accumulated data, it is important and urgent to perform a quantitative synthesis of these evidences. We therefore undertake a large meta-analysis of studies of the association between TCF7L2 gene polymorphisms and T2DM. To exclude heterogeneity of these studies, we stratified the data by Hardy-Weinberg equilibrium (HWE), publishing time, ethnicity, body mass index (BMI), diagnosis and age.
###end p 14
###begin p 15
###xml 28 30 28 30 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B77">77</xref>
###xml 68 75 68 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 108 110 108 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B78">78</xref>
###xml 111 113 111 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B80">80</xref>
###xml 248 250 248 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B77">77</xref>
###xml 323 325 323 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 326 328 326 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B55">55</xref>
###xml 329 331 329 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B57">57</xref>
###xml 332 334 332 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B63">63</xref>
###xml 335 337 335 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B68">68</xref>
###xml 338 340 338 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B69">69</xref>
###xml 341 343 341 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B71">71</xref>
###xml 344 346 344 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B73">73</xref>
###xml 347 349 347 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B76">76</xref>
###xml 350 352 350 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B81">81</xref>
###xml 353 355 353 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B83">83</xref>
###xml 434 441 434 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 527 529 527 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B77">77</xref>
###xml 1080 1087 1080 1087 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
Although one meta-analysis [77] and several narrative reviews about TCF7L2 gene and T2DM had been reported [78-80], Succedent studies have now made more data available. Compared with the only one meta-analysis written by Cauchi and his colleagues [77] and published online in May, 2007, 28 more studies from 14 new papers [53,55,57,63,68,69,71,73-76,81-83]were available to us. And that, this meta-analysis of the association between TCF7L2 gene and T2DM, only summarized IVS3C>T polymorphism by just analyze allele frequency [77], the authors did not generalize the association between other important variations such as IVS4G>T, IVS3T>C and IVS4G>C polymorphisms and T2DM. Further, the only meta-analysis was based on published data, namely, without stratification, and, was thus limited in the interpretations they allowed. However, using the original data, we are able to explore more deeply, searching for sources of heterogeneity. Thus, we carried out a large meta-analysis to conduct a broad comprehensive and quantitative assessment on the association between variants of TCF7L2 gene and T2DM, and then, to perform a detailed examination of sources of heterogeneity. We sought to estimate magnitude of the genetic association as well as the genetic mode of action, and to determine the extent of heterogeneity in the strength of associations between different studies.
###end p 15
###begin title 16
Methods
###end title 16
###begin title 17
Search strategy and inclusion criteria
###end title 17
###begin p 18
###xml 223 230 223 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 301 308 301 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 342 343 342 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 465 471 465 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2</italic>
###xml 477 484 477 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
We conducted a comprehensive search of the US National Library of Medicine's PubMed, OMIM, ISI Web of Science, and Embase databases for all genetic association studies on at least one of the above four polymorphisms in the TCF7L2 gene and T2DM published from March, 2006, when the association between TCF7L2 gene and T2DM was first reported [2], through March, 2008. The search strategy was based on combination of the key words "transcription factor 7-like 2" or "TCF7L2" or "TCF7L2 gene polymorphism", and "diabetes" or "diabetes 2" or "type 2 diabetes" or "type 2 diabetes mellitus" or "T2D" or "T2DM". The references of all computer-identified publications were searched for additional studies, and the PubMed option "Related Articles" was used to search for potentially relevant papers. Reference lists in retrieved articles were also screened.
###end p 18
###begin p 19
Searching was performed in duplicate by two independent reviewers (YZ and JYY). Without any language restriction (we will translate articles published in other languages into English by professional interpreters), we only selected published manuscripts (including their online supporting materials and the original data kindly sent by the authors) if they met the following criteria: 1) the publication was a population-based association study (family-based study design with linkage considerations was excluded), regardless of sample size, and 2) there were enough results for extraction of data, that is, the number of subjects with each allele and genotype in the T2DM and control groups. Where eligible papers had insufficient information, we contacted authors by e-mail or mail for additional information. In the case of sequential or multiple publications of analyses of the same data or overlapping data sets, the publication that reported data from the largest or most recent study was included.
###end p 19
###begin title 20
Data extraction
###end title 20
###begin p 21
###xml 178 180 178 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B84">84</xref>
Data were extracted independently and in duplicate by two investigators (YZ and JJY) who used the recommended guidelines for reporting on meta-analyses of observational studies [84]. The following data were extracted from the eligible studies: authors, journal and year of publication, country of origin, selection and characteristics of cases and controls, demographic data, ethnicity of the study population (Caucasian, North European, East Asian, African, Middle Eastern, American, or Pacific Asian), numbers of eligible and genotyped cases and controls, and genotype distributions in cases and controls and available subgroups thereof. Furthermore, we examined whether matching had been used; whether there was specific mention of blinding of the genotyping personnel to the clinical status of subjects; whether the genotyping method used had been validated; and whether genotype frequencies in control groups were in HWE. Any disagreement was adjudicated by a third author (YWZ).
###end p 21
###begin title 22
Statistical Analysis
###end title 22
###begin p 23
###xml 137 144 137 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 479 481 479 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 481 482 481 482 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 499 501 499 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 501 502 501 502 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 540 542 540 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 542 543 542 543 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 560 562 560 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 562 563 562 563 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 601 603 601 603 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 603 604 603 604 <sub xmlns:xlink="http://www.w3.org/1999/xlink">5</sub>
###xml 621 623 621 623 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 623 624 623 624 <sub xmlns:xlink="http://www.w3.org/1999/xlink">6</sub>
###xml 662 664 662 664 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 664 665 664 665 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 682 684 682 684 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 684 685 684 685 <sub xmlns:xlink="http://www.w3.org/1999/xlink">8</sub>
###xml 1026 1028 1026 1028 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B71">71</xref>
We used the odds ratio as the metric of choice and it was estimated for each study. In order to explore the possible association between TCF7L2 gene polymorphisms and T2MD and to avoid excessive comparisons, we calculated the odds ratio by two methods, namely, allele comparison (i.e., T allele vs. C allele in IVS3C>T polymorphism), and genotype comparison, that is, comparing the risk variant homozygotes and heterozygotes with wild homozygotes, respectively (i.e., TT vs. CC (OR1) and TC vs. CC (OR2) in IVS3C>T polymorphism; TT vs. GG (OR3) and TG vs. GG (OR4) in IVS4G>T polymorphism; CC vs. TT (OR5) and CT vs. TT (OR6) in IVS3T>C polymorphism; CC vs. TT (OR7) and CT vs. TT (OR8) in IVS4G>C polymorphism). We estimated and characterized the summary prevalence of risk allele by using only the data on controls. When we analyze genotype data for meta-analysis, cells with zero count had 0.5 been added. In addition, we calculated the population attributable risk (PAR) of risk allele according to method of Chang et al [71].
###end p 23
###begin p 24
###xml 286 288 286 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B85">85</xref>
###xml 346 348 346 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B86">86</xref>
###xml 408 410 408 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B87">87</xref>
We first compared alleles for cases and controls in order to detect overall differences and genetic association. Allele frequencies were computed for studies reporting only genotypic data. Pooled odds ratio were computed three times, by the fixed-effects method of Mantel and Haenszel [85], by the random-effects method of DerSimonian and Laird [86], and by the Bayesian random-effects method of Warn et al [87]. Unless stated otherwise, random-effects estimates (DerSimonian and Laird) are reported here.
###end p 24
###begin p 25
###xml 25 32 25 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 393 395 393 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B88">88</xref>
###xml 459 461 459 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 461 463 461 463 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 466 468 466 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 468 470 468 470 <sub xmlns:xlink="http://www.w3.org/1999/xlink">8 </sub>
###xml 544 546 544 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B88">88</xref>
###xml 753 755 753 755 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 755 757 755 757 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 767 769 767 769 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 769 771 769 771 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 781 782 776 777 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 787 789 782 784 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 789 791 784 786 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4 </sub>
###xml 801 803 796 798 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 803 805 798 800 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 815 816 805 806 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 821 823 811 813 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 823 825 813 815 <sub xmlns:xlink="http://www.w3.org/1999/xlink">6 </sub>
###xml 835 837 825 827 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 837 839 827 829 <sub xmlns:xlink="http://www.w3.org/1999/xlink">5 </sub>
###xml 849 850 834 835 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 859 861 844 846 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 861 863 846 848 <sub xmlns:xlink="http://www.w3.org/1999/xlink">8 </sub>
###xml 873 875 858 860 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 875 877 860 862 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7 </sub>
###xml 887 888 867 868 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 907 909 887 889 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B88">88</xref>
###xml 1262 1264 1212 1214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B85">85</xref>
###xml 1325 1327 1275 1277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B86">86</xref>
Our primary analysis for TCF7L2 gene polymorphisms and T2DM is based on genotype comparisons in order that magnitude of the genetic association and the genetic mode of action can be identified exactly. Once an overall gene effect was confirmed by the allele comparison, the genotype effects and genetic model were estimated by using the genetic model-free approach suggested by Minelli et al [88], where no assumptions about genetic models were required. The OR1 to OR8 were calculated by using multivariate meta-analysis with Bayesian method [88]. The logarithm (log) odds ratios were modeled on the base of both between and within study variations. Four separate stochastic lambda values (reflecting the genetic model), consisting of the ratios of logOR2 versus logOR1 for lambda1, logOR4 versus logOR3 for lambda2, logOR6 versus logOR5 for lambda3, and logOR8 versus logOR7 for lambda4, were calculated [88]. The parameter lambda capture information about the genetic mode of action, briefly, the model is a recessive model if lambda = 0, a codominant model if lambda = 0.5, a dominant model if lambda = 1, and homozygous or heterosis model if lambda < 0 or lambda > 1. Pooled odds ratio were also computed by the fixed-effects method of Mantel and Haenszel [85] and by the random-effects method of DerSimonian and Laird [86]. Unless stated otherwise, Bayesian estimates are reported here.
###end p 25
###begin p 26
###xml 150 152 150 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B89">89</xref>
###xml 185 187 185 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 632 633 632 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 666 668 666 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B90">90</xref>
###xml 684 686 684 686 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F </italic>
###xml 798 800 798 800 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B91">91</xref>
We tested for deviations from Hard-Weinberg equilibrium (HWE) in both case and control populations by using the exact method reported by Emigh et al [89] whether the author provide the P values of HWE or not. For above allele-based and genotype-base analyses, we took two methods to handle Hard-Weinberg disequilibrium. Firstly, we performed sensitivity analyses by including by including and excluding studies in Hard-Weinberg disequilibrium (case and control group were all considered). Secondly, we included all studies regardless of HWE and instead adjusted for the degree of disequilibrium by using the inbreeding coefficient (F) suggested by Trikalinos et al [90]. Briefly, the F was estimated for each study by using data in the control group. Predicted genotype frequencies were estimated [91] and used instead of the observed frequencies in the summary analysis of magnitude and genetic model.
###end p 26
###begin p 27
###xml 114 116 114 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Q </italic>
###xml 127 129 127 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B92">92</xref>
###xml 176 178 176 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 200 202 200 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B92">92</xref>
###xml 220 221 220 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink">I</italic>
###xml 221 223 221 223 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 355 357 355 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B93">93</xref>
###xml 358 360 358 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B94">94</xref>
###xml 433 435 433 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B94">94</xref>
###xml 436 438 436 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B95">95</xref>
###xml 453 454 453 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink">I</italic>
###xml 454 456 454 456 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 748 749 748 749 <italic xmlns:xlink="http://www.w3.org/1999/xlink">I</italic>
###xml 749 751 749 751 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 797 799 797 799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B94">94</xref>
###xml 800 802 800 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B95">95</xref>
###xml 884 886 884 886 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 886 888 886 888 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 892 894 892 894 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 894 896 894 896 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 922 924 922 924 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 924 926 924 926 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 930 932 930 932 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 932 934 932 934 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4 </sub>
###xml 960 962 960 962 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 962 964 962 964 <sub xmlns:xlink="http://www.w3.org/1999/xlink">6 </sub>
###xml 968 970 968 970 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 970 972 970 972 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7 </sub>
###xml 998 1000 998 1000 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 1000 1002 1000 1002 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7 </sub>
###xml 1006 1008 1006 1008 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 1008 1010 1008 1010 <sub xmlns:xlink="http://www.w3.org/1999/xlink">8 </sub>
###xml 1268 1270 1268 1270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B96">96</xref>
###xml 1271 1273 1271 1273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B98">98</xref>
###xml 1577 1578 1575 1576 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 1607 1608 1603 1604 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 1888 1890 1884 1886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B99">99</xref>
###xml 1967 1970 1963 1966 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B100">100</xref>
###xml 2002 2005 1998 2001 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B101">101</xref>
In sensitivity analysis, we estimated between-study heterogeneity across all eligible comparisons using Cochran's Q statistic [92]. Heterogeneity was considered significant at P value less than 0.10 [92]. We also report I2 statistic, which describes the percentage of variability in point estimates due to sample heterogeneity rather than sampling error [93,94], and can quantify heterogeneity irrespective of the number of studies [94,95]. As a guide, I2 values less than 25 percent may be considered "low", values of 31 percent to 56 percent have been defined as indicating "low" to "moderate" heterogeneity, whereas values greater than 56 percent are considered indicative of "notable" heterogeneity, and "large" heterogeneity is stipulated for I2 values of larger than or equal to 75 percent [94,95]. The examination of heterogeneity was performed separately for two odds ratios (OR1 and OR2 for IVS3C>T polymorphism, OR3 and OR4 for IVS4G>T polymorphism, OR6 and OR7 for IVS3T>C polymorphism, OR7 and OR8 for IVS4G>C polymorphism) in genotype-based analysis. If there was heterogeneity on at least one of these two odds ratios, the source of the heterogeneity was explored by fitting a covariable (such as age, gender, ethnicity, BMI) in a meta-regression model [96-98]. Possible subgroup analyses were involved in ethnicity (Caucasians, North Europeans, East Asians, Indians and other racial groups), age (< 65 years vs. >/= 65 years), diagnosis (normal diagnosis vs. no diagnosis or false diagnosis), publishing time (2006 vs. 2007 and 2008) and BMI (normal (< 30.0 kg/m2) vs. abnormal (>/= 30.0 kg/m2) according to the meta-regression analysis. Logistic regression analysis was used to compare odds ratios among these possible groups. In addition, genetic association studies may be especially susceptibility to the selective publication of positive findings on gene association [99]. In order to investigate the publication bias among studies, funnel plots [100] and cumulative meta-analysis [101] were used.
###end p 27
###begin p 28
###xml 60 63 60 63 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B102">102</xref>
###xml 72 76 72 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">meta</italic>
###xml 78 83 78 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink">metan</italic>
###xml 85 93 85 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink">metabias</italic>
###xml 95 102 95 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink">metacum</italic>
###xml 108 116 108 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">metareg </italic>
###xml 333 336 333 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B103">103</xref>
###xml 559 562 559 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CrI</italic>
###xml 808 810 808 810 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
All analyses were conducted in Stata software, version 9.0 [102], using meta, metan, metabias, metacum, and metareg commands, except for the Bayesian method of genotype-based analysis. We fit the Bayesian models by using Markov chain Monte Carlo (MCMC) methods with Bayesian framework and perform our inferences using WinBUGS 1.4.3 [103], taking advantage of its flexibility as well as its ability to incorporate full uncertainty in all unknown parameters. Bayesian analyses yield credible intervals rather than confidence intervals; a 95% credible interval (CrI) describes a range in which the probability that the unknown quantity lies within this interval, after seeing the data, is 95%. A 'burn-in' of 10,000 iterations is carried out for models, followed by 50,000 iterations for parameter estimates. A P value less than 0.05 was considered statistically significant, except for tests of heterogeneity, where a level of 0.10 was used.
###end p 28
###begin title 29
Results
###end title 29
###begin title 30
Eligible studies
###end title 30
###begin p 31
###xml 127 129 127 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B57">57</xref>
###xml 130 132 130 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B71">71</xref>
###xml 242 244 242 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B68">68</xref>
###xml 575 576 575 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 577 579 577 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 580 582 580 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B55">55</xref>
###xml 583 585 583 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B71">71</xref>
###xml 586 588 586 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B74">74</xref>
###xml 589 591 589 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B75">75</xref>
###xml 592 594 592 594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B77">77</xref>
###xml 595 597 595 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B81">81</xref>
###xml 598 600 598 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B83">83</xref>
###xml 715 716 715 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 736 738 736 738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B62">62</xref>
###xml 758 760 758 760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B67">67</xref>
###xml 781 783 781 783 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B82">82</xref>
###xml 821 823 821 823 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B74">74</xref>
###xml 840 842 840 842 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B75">75</xref>
###xml 863 865 863 865 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B77">77</xref>
###xml 903 910 903 910 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 1046 1047 1046 1047 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 1178 1179 1178 1179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 1180 1182 1180 1182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 1183 1185 1183 1185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B55">55</xref>
###xml 1186 1188 1186 1188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B57">57</xref>
###xml 1189 1191 1189 1191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B71">71</xref>
###xml 1192 1194 1192 1194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B74">74</xref>
###xml 1195 1197 1195 1197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B75">75</xref>
###xml 1198 1200 1198 1200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B77">77</xref>
###xml 1201 1203 1201 1203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B81">81</xref>
###xml 1204 1206 1204 1206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B83">83</xref>
###xml 1278 1279 1278 1279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 1377 1378 1377 1378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 1484 1485 1484 1485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 1588 1589 1588 1589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
Totally eighty-nine papers were identified across Medline and Embase on the base of our search strategies. Two of the studies [57,71]did not have genotypic data, but the authors friendly sent the supplementary information to us. Parra et al [68], reported four samples, that is, two Mexican American populations, one Spanish and one Nigerian population. With no controls of last three populations, we combined the two Mexican samples and then, discarded the Spanish and Nigerian samples in meta-analysis of polymorphism of IVS3C>T and IVS4G>T. Therefore, 25 eligible papers [2,53,55-71,74,75,77,81-83], including 36 studies (multiple studies performed in one paper in particular: 3 studies in paper of Grant et al [2], Horikoshi et al [62], Humphries et al [67], and Miyake et al [82]; 2 studies in paper of Scott et al [74], Sladek et al [75], and Cauchi et al [77]), examining the association between TCF7L2 gene polymorphisms and T2DM were identified by the inclusion criteria and all of them were written in English (Table 1, Additional file 1). The eligible studies for analysis involved in a total of 35,843 cases with T2DM and 39,123 controls. 35 studies from 24 papers [2,53,55,57-71,74,75,77,81-83] contained data for the IVS3C>T polymorphism (Table 2, Additional file 1), 10 studies from 8 papers contained data for the IVS3T>C polymorphism (Table 3, Additional file 1), 21 papers involved in 29 studies contained data for the IVS4G>T polymorphism (Table 4, Additional file 1), and 9 papers including 15 samples contained data for IVS4G>C polymorphism (Table 5, Additional file 1).
###end p 31
###begin p 32
###xml 129 130 129 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 453 454 453 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 524 526 524 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B60">60</xref>
###xml 527 529 527 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B66">66</xref>
###xml 530 532 530 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B67">67</xref>
###xml 574 576 574 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 619 621 619 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B56">56</xref>
###xml 652 654 652 654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B55">55</xref>
###xml 655 657 655 657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B67">67</xref>
###xml 658 660 658 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B70">70</xref>
###xml 661 663 661 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B83">83</xref>
###xml 733 735 733 735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B58">58</xref>
###xml 736 738 736 738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B65">65</xref>
###xml 886 888 886 888 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 81 89 <span type="species:ncbi:9606">patients</span>
There was considerable diversity of ethnic groups. Eligibility criteria for T2DM patients were shown in Table 1 (Additional file 1). Controls were mainly healthy populations who were described as nondiabetic and/or, Normoglycemic, and/or normal glucose tolerance (NGT), although varying details were presented regarding the extent of testing that had been done to excluded controls with impaired glucose tolerance and diabetes (table 1, Additional file 1). Remaining 3 investigations did not report the details of controls [60,66,67]. 1 study matched for geographic region [53]; 1 study matched for age, race, and BMI [56]; 5 studies matched for race [55,67,70,83]; and one study 1 study matched for age, sex, and geographic region [58,65]. The other investigations did not provide for the details of the matching information. Detailed characteristics of each investigation, along with P values for testing HWE, are listed in the Table 2-5 (Addional file 1) for IVS3C>T polymorphism, IVS3T>C polymorphism, IVS4G>T polymorphism and IVS4G>C polymorphism, respectively.
###end p 32
###begin title 33
IVS3C>T polymorphism
###end title 33
###begin p 34
###xml 147 148 147 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
The eligible studies for analysis of IVS3C>T polymorphism included a total of 33,135 cases with T2DM and 36,316 controls (Table 2, Additional file 1). Allele and genotype data were available for all the cases and controls in the eligible studies. There was no evidence of Hard-Weinberg disequilibrium in both cases and controls.
###end p 34
###begin title 35
Bias diagnostics
###end title 35
###begin p 36
###xml 276 277 276 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 279 280 279 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 285 286 285 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 321 323 321 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 342 344 342 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink">z </italic>
###xml 363 365 363 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 384 386 384 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink">z </italic>
###xml 409 411 409 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 430 432 430 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink">z </italic>
###xml 462 463 462 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 465 466 465 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 472 473 472 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 849 850 849 850 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 975 982 975 982 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 1066 1067 1066 1067 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 1079 1080 1079 1080 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
We did not find any evidence of publication bias of the eligible studies. Funnel plots for the comparisons most commonly made, that is, for T allele vs. C allele, T homozygotes (TT) vs. C homozygotes (CC), and heterozygotes (TC) vs. C homozygotes (CC) are indicated in figure 1, 2 and 3. These three plots give corrected P = 0.410 (corrected z = 0.82), corrected P = 0.379 (corrected z = 0.88), and corrected P = 0.426 (corrected z = 0.80), respectively. Figure 4, 5, and 6 indicate the cumulative meta-analysis after each study from March 2006 to February 2008, for T allele vs. C allele, T homozygotes vs. C homozygotes, and heterozygotes vs. C homozygotes. The random-effects odds ratio of T homozygotes vs. C homozygotes waved slightly among studies performed in 2006 and has changed very little from around 2.0 after the eleventh study (figure 5). Cumulative meta-analysis of the other two comparisons by year of publication showed that the association between T2DM and TCF7L2 IVS3C>T polymorphism has remained significant and been consistent over time (figure 4 and figure 6).
###end p 36
###begin p 37
###xml 84 86 84 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink">z </italic>
###xml 104 106 104 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 0 114 0 114 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Funnel plots of rs7903146 polymorphism studies for T allele vs. C allele (corrected <italic>z </italic>= 0.82, corrected <italic>P </italic>= 0.410)</bold>
Funnel plots of rs7903146 polymorphism studies for T allele vs. C allele (corrected z = 0.82, corrected P = 0.410).
###end p 37
###begin p 38
###xml 94 96 94 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink">z </italic>
###xml 114 116 114 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 0 124 0 124 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Funnel plots of rs7903146 polymorphism studies for T homozygotes vs. C homozygotes (corrected <italic>z </italic>= 0.02, corrected <italic>P </italic>= 0.987)</bold>
Funnel plots of rs7903146 polymorphism studies for T homozygotes vs. C homozygotes (corrected z = 0.02, corrected P = 0.987).
###end p 38
###begin p 39
###xml 94 96 94 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink">z </italic>
###xml 114 116 114 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 0 124 0 124 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Funnel plots of rs7903146 polymorphism studies for heterozygotes vs. C homozygotes (corrected <italic>z </italic>= 0.80, corrected <italic>P </italic>= 0.426)</bold>
Funnel plots of rs7903146 polymorphism studies for heterozygotes vs. C homozygotes (corrected z = 0.80, corrected P = 0.426).
###end p 39
###begin p 40
###xml 93 100 93 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 0 139 0 139 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Cumulative meta-analysis of the odds ratios of association between rs7903146 polymorphism of <italic>TCF7L2 </italic>gene and T2DM for T allele vs. C allele</bold>
Cumulative meta-analysis of the odds ratios of association between rs7903146 polymorphism of TCF7L2 gene and T2DM for T allele vs. C allele.
###end p 40
###begin p 41
###xml 93 100 93 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 0 149 0 149 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Cumulative meta-analysis of the odds ratios of association between rs7903146 polymorphism of <italic>TCF7L2 </italic>gene and T2DM for T homozygotes vs. C homozygotes</bold>
Cumulative meta-analysis of the odds ratios of association between rs7903146 polymorphism of TCF7L2 gene and T2DM for T homozygotes vs. C homozygotes.
###end p 41
###begin p 42
###xml 93 100 93 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 0 149 0 149 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Cumulative meta-analysis of the odds ratios of association between rs7903146 polymorphism of <italic>TCF7L2 </italic>gene and T2DM for heterozygotes vs. C homozygotes</bold>
Cumulative meta-analysis of the odds ratios of association between rs7903146 polymorphism of TCF7L2 gene and T2DM for heterozygotes vs. C homozygotes.
###end p 42
###begin title 43
Allele comparisons
###end title 43
###begin p 44
###xml 119 126 119 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 189 191 189 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CI</italic>
###xml 297 299 297 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CI</italic>
###xml 346 348 346 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CI</italic>
###xml 389 391 389 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CI</italic>
###xml 428 430 428 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CI</italic>
###xml 468 470 468 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CI</italic>
###xml 567 574 567 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 765 767 765 767 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 767 771 767 771 <sub xmlns:xlink="http://www.w3.org/1999/xlink">TvC </sub>
###xml 784 786 784 786 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CI</italic>
###xml 861 863 861 863 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 928 930 928 930 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Q </italic>
###xml 941 943 941 943 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 952 953 952 953 <italic xmlns:xlink="http://www.w3.org/1999/xlink">I</italic>
###xml 953 955 953 955 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 990 991 990 991 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 1001 1002 1001 1002 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7</xref>
###xml 723 730 <span type="species:ncbi:9606">persons</span>
Data from control groups were used for calculating the summary allele frequency. The frequency of the risk allele T at TCF7L2 gene among controls was 20.2 percent (95% confidence interval (CI): 16.3, 24.1) and was considerable variation in different ethnic populations (for Caucasians, 29.0% (95% CI: 28.3, 29.7); for North Europeans, 21.9% (95% CI: 16.2, 27.6); for East Asians, 3.2 (95% CI: 2.6, 3.9); for Indians, 28.1% (95% CI: 25.9, 30.3); for others, 23.0% (95% CI: 9.4, 36.6)). We first contained all the 35 studies to evaluate the overall association between TCF7L2 IVS3C>T polymorphism and T2DM. With our allele-based analysis, the pooled odds ratio suggested a 1.416-fold increase in susceptibility to T2DM among persons with the T allele (random-effects ORTvC = 1.416, 95% CI: 1.346, 1.491), with a finding that was highly statistically significant (P = 0.000), but there was significant between-study heterogeneity (Q = 104.966, P = 0.000; I2 = 67.6%) (Table 6 [Additional file 1], figure 7).
###end p 44
###begin p 45
###xml 61 68 61 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 0 107 0 107 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Odds ratios of association between rs7903146 polymorphism of <italic>TCF7L2 </italic>gene and T2DM for T allele vs. C allele</bold>
Odds ratios of association between rs7903146 polymorphism of TCF7L2 gene and T2DM for T allele vs. C allele.
###end p 45
###begin title 46
Genotype comparisons
###end title 46
###begin p 47
###xml 26 33 26 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 156 158 156 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 158 159 158 159 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 179 181 179 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 181 182 181 182 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 515 517 515 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 517 519 517 519 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 558 561 558 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CrI</italic>
###xml 639 641 639 641 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 641 643 641 643 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 663 666 663 666 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CrI</italic>
###xml 730 732 730 732 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Q </italic>
###xml 742 744 742 744 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 753 754 753 754 <italic xmlns:xlink="http://www.w3.org/1999/xlink">I</italic>
###xml 754 756 754 756 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 772 773 772 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8</xref>
###xml 834 836 834 836 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Q </italic>
###xml 846 848 846 848 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 857 858 857 858 <italic xmlns:xlink="http://www.w3.org/1999/xlink">I</italic>
###xml 858 860 858 860 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 876 877 876 877 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9</xref>
###xml 935 937 930 932 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 959 962 954 957 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CrI</italic>
The genotype frequency of TCF7L2 IVS3C>T polymorphism between case and control groups is characterized in web table. The genotype effects for TT versus CC (OR1) and TC versus CC (OR2) were calculated for each study (data are not shown and available from the first author on request). In our primary concern, multivariate meta-analysis was conducted to estimate the pooled effects and there was an significant increased risk of T2DM among populations with both homozygous variant TT genotype (Bayesian random-effect OR1 = 1.968, 95 percent credible interval (CrI): 1.790, 2.157) and heterozygous variant TC genotype (Bayesian random-effect OR2 = 1.406, 95 percent CrI: 1.341, 1.476), with a "moderate" between-study heterogeneity (Q = 66.102, P = 0.001, I2 = 48.6%, figure 8) in the former and a "notable" between-study heterogeneity (Q = 84.028, P = 0.000, I2 = 59.5%, figure 9) in the latter. The estimated stochastic parameter lambda1 was 0.504 (95 percent CrI: 0.461, 0.551), which suggested a codominant genetic mode of action.
###end p 47
###begin p 48
###xml 61 68 61 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 0 117 0 117 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Odds ratios of association between rs7903146 polymorphism of <italic>TCF7L2 </italic>gene and T2DM for T homozygotes vs. C homozygotes</bold>
Odds ratios of association between rs7903146 polymorphism of TCF7L2 gene and T2DM for T homozygotes vs. C homozygotes.
###end p 48
###begin p 49
###xml 61 68 61 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 0 117 0 117 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Odds ratios of association between rs7903146 polymorphism of <italic>TCF7L2 </italic>gene and T2DM for heterozygotes vs. C homozygotes</bold>
Odds ratios of association between rs7903146 polymorphism of TCF7L2 gene and T2DM for heterozygotes vs. C homozygotes.
###end p 49
###begin title 50
Examination of heterogeneity
###end title 50
###begin p 51
###xml 144 146 144 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 146 148 146 148 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 200 202 197 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 217 219 214 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 219 221 216 218 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 238 240 232 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 624 626 618 620 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 626 628 620 622 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 632 634 626 628 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 634 635 628 629 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 720 721 714 715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 1018 1020 1012 1014 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 1020 1022 1014 1016 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 1034 1036 1028 1030 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 1036 1038 1030 1032 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 1064 1065 1058 1059 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 1079 1081 1073 1075 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 1081 1083 1075 1077 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 1240 1243 1234 1237 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CrI</italic>
###xml 1270 1273 1264 1267 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CrI</italic>
###xml 1300 1303 1294 1297 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CrI</italic>
###xml 1330 1333 1324 1327 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CrI</italic>
###xml 1360 1363 1354 1357 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CrI</italic>
###xml 1394 1397 1388 1391 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CrI</italic>
###xml 1443 1445 1437 1439 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 1445 1447 1439 1441 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 1483 1486 1477 1480 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CrI</italic>
###xml 1535 1538 1529 1532 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CrI</italic>
###xml 1577 1580 1571 1574 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CrI</italic>
###xml 1619 1622 1613 1616 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CrI</italic>
###xml 1669 1672 1663 1666 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CrI</italic>
###xml 1719 1722 1713 1716 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CrI</italic>
###xml 1785 1786 1779 1780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 1819 1821 1808 1810 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 1865 1868 1854 1857 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CrI</italic>
###xml 1916 1919 1905 1908 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CrI</italic>
###xml 1966 1969 1955 1958 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CrI</italic>
###xml 2020 2023 2009 2012 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CrI</italic>
###xml 2080 2083 2069 2072 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CrI</italic>
###xml 2142 2145 2131 2134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CrI</italic>
Meta-regression was used to explore the source of heterogeneity and it was found that ethnicity was the only co-variable associated with both lnOR1 (meta-regression beta coefficient (beta) = -0.0993, P = 0.002) and lnOR2 (beta = -0.0360, P = 0.002). We then did a subgroup analysis by stratifying study samples into five ethnic groups, that is, Caucasians (11 samples), North European (6 samples), East Asian (9 samples), Indians (4 samples) and other racial descent group (5 samples), and found that this stratification can remove all the between-study heterogeneity among North Europeans, East Asians and Indians for both OR1 and OR2, rather than that among Caucasians and other racial group (Table 6, Additional file 1). We then did a further subgroup analysis of Caucasians by stratifying them into French Caucasians versus other Caucasians and extracted the studies with African populations for an independent analysis, and found that such analyses can only remove heterogeneity among these three populations for OR1 rather than OR2 (Table 6, Additional file 1). The pooled OR1 for six ethnic groups by descending ranking, that is, French Caucasians, other Caucasians, North Europeans, Africans, Indians, and East Asians, was 3.051(95%CrI: 2.039, 4.906), 1.989 (95%CrI: 1.807, 2.216), 1.944 (95%CrI: 1.639, 2.284), 1.802 (95%CrI: 1.292, 2.480), 1.669 (95%CrI: 1.373. 2.104), and 1.595 (95%CrI: 0.537, 2.653), respectively, and the pooled OR2 by descending ranking was 1.766 (95%CrI: 1.427, 2.278) for French Caucasians, 1.696 (95%CrI:1.258, 2.242) for Africans, 1.406 (95%CrI: 1.230, 1.617) for Indians, 1.357 (95%CrI: 1.255, 1.474) for North Europeans, 1.352 (95%CrI: 1.160, 1.591) for East Asians, and 1.349 (95%CrI: 1.278, 1.431) for other Caucasians (Table 2, Additional file 1). The estimated parameter lambda1 by descending ranking was 0.981 (95 percent CrI: 0.759, 0.999) for Africans, 0.676 (95 percent CrI: 0.452, 0.957) for Indians, 0.670 (95 percent CrI: 0.278, 0.995) for East Asians, 0.511 (95 percent CrI: 0.449, 0.578) for French Caucasians, 0.472 (95 percent CrI: 0.345, 0.624) for North Europeans, and 0.436 (95 percent CrI: 0.366, 0.511) for other Caucasians, which suggested codominant genetic mode of action among these different ethnic populations except for Africans where dominant mode of action was found.
###end p 51
###begin p 52
###xml 44 46 44 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 46 48 46 48 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 54 56 54 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 56 58 56 58 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 185 187 185 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 187 188 187 188 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 206 208 203 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 223 225 220 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 225 226 222 223 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 244 246 238 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 321 328 315 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 429 430 423 424 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 459 460 451 452 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 531 533 523 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 533 535 525 527 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 536 538 528 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Q </italic>
###xml 548 550 540 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 559 560 551 552 <italic xmlns:xlink="http://www.w3.org/1999/xlink">I</italic>
###xml 560 562 552 554 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 577 579 569 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 579 581 571 573 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 582 584 574 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Q </italic>
###xml 594 596 586 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 605 606 597 598 <italic xmlns:xlink="http://www.w3.org/1999/xlink">I</italic>
###xml 606 608 598 600 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 629 631 621 623 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 631 632 623 624 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 634 636 626 628 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 636 637 628 629 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 649 651 636 638 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 698 701 685 688 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CrI</italic>
###xml 728 731 715 718 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CrI</italic>
###xml 762 765 749 752 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CrI</italic>
###xml 807 809 794 796 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 809 810 796 797 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 812 814 799 801 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 814 815 801 802 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 827 829 809 811 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 878 881 860 863 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CrI</italic>
###xml 908 911 890 893 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CrI</italic>
###xml 942 945 924 927 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CrI</italic>
###xml 1116 1118 1098 1100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 1118 1120 1100 1102 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 1121 1123 1103 1105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1138 1140 1120 1122 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 1140 1142 1122 1124 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 1143 1145 1125 1127 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
Although BMI was not associated with both lnOR1 and lnOR2 by separate meta-regression analysis, the significant association was found when we evaluate it together with ethnicity (for lnOR1, beta = -0.0512, P = 0.038; for lnOR2, beta = -0.0311, P = 0.004). In addition, some references reported that BMI may interact with TCF7L2 gene to increase the risk of T2MD. Therefore, we did a subgroup analysis for BMI (normal (< 30.0 kg/m2) vs. abnormal (>/= 30.0 kg/m2). However, such stratification cannot remove heterogeneity for both lnOR1 (Q = 35.017, P = 0.006, I2 = 52.1%) and lnOR2 (Q = 28.046, P = 0.013, I2 = 50.0%). The pooled OR1, OR2, and lambda1 for populations with normal BMI were 2.017 (95%CrI: 1.711, 2.347), 1.470 (95%CrI: 1.350, 1.609), and 0.554 (95%CrI: 0.481, 0.637), respectively. The pooled OR1, OR2, and lambda1 for populations with abnormal BMI were 1.931 (95%CrI: 1.670, 2.213), 1.337 (95%CrI: 1.250, 1.431), and 0.441 (95%CrI: 0.387, 0.500), respectively. Logistic regression analysis indicated that there was no significant difference between populations with normal and abnormal BMI for both lnOR1 (P = 0.855) and lnOR2 (P = 0.716).
###end p 52
###begin title 53
IVS4G>T
###end title 53
###begin p 54
###xml 217 218 217 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 51 63 <span type="species:ncbi:9606">participants</span>
Our searches identified 29 studies (totally 57,235 participants; 28,188 cases of T2DM, 29,047 controls) meeting our inclusion criteria. All of these studies examined the IVS4G>T polymorphism (Table 4, Additional file 1). Allele and genotype data were available for all the cases and controls in the eligible studies. There was no evidence of Hard-Weinberg disequilibrium in both cases and controls.
###end p 54
###begin title 55
Bias diagnostics
###end title 55
###begin p 56
###xml 253 255 253 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F10">10</xref>
###xml 257 259 257 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F11">11</xref>
###xml 264 266 264 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F12">12</xref>
###xml 308 310 308 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 329 331 329 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink">z </italic>
###xml 350 352 350 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 371 373 371 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink">z </italic>
###xml 396 398 396 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 417 419 417 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink">z </italic>
###xml 449 451 449 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F13">13</xref>
###xml 453 455 453 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F14">14</xref>
###xml 460 462 460 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F15">15</xref>
###xml 788 790 788 790 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F13">13</xref>
###xml 984 986 984 986 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F14">14</xref>
###xml 1117 1124 1117 1124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 1208 1210 1208 1210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F15">15</xref>
There was no evidence of small study bias and publication bias for any comparisons. Funnel plots for the comparisons made for T allele vs. G allele, T homozygotes (TT) vs. G homozygotes (GG), and heterozygotes (TG) vs. G homozygotes are shown in figure 10, 11 and 12. These three funnel plots give corrected P = 0.339 (corrected z = 0.96), corrected P = 0.536 (corrected z = 0.62), and corrected P = 0.442 (corrected z = 0.77), respectively. Figure 13, 14 and 15 indicate the cumulative meta-analysis after each study from March 2006 to February 2008, for allele-based analysis and two genotype-based models of IVS4G>T polymorphism. The random-effects odds ratio of allele-based analysis was significant more than 1 and changed very little from around 1.379 after the first study (figure 13). The random-effects odds ratio of T homozygotes vs. G homozygotes waved slightly among studies performed in 2006 and has changed very little from around 1.884 after the eleventh study (figure 14). Cumulative meta-analysis of heterozygotes vs. G homozygotes by year of publication showed that the association between T2DM and TCF7L2 IVS4G>T polymorphism has remained significant and been consistent over time (figure 15).
###end p 56
###begin p 57
###xml 85 87 85 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">z </italic>
###xml 105 107 105 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 0 115 0 115 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Funnel plots of rs12255372 polymorphism studies for T allele vs. G allele (corrected <italic>z </italic>= 0.96, corrected <italic>P </italic>= 0.339)</bold>
Funnel plots of rs12255372 polymorphism studies for T allele vs. G allele (corrected z = 0.96, corrected P = 0.339).
###end p 57
###begin p 58
###xml 95 97 95 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink">z </italic>
###xml 115 117 115 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 0 125 0 125 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Funnel plots of rs12255372 polymorphism studies for T homozygotes vs. G homozygotes (corrected <italic>z </italic>= 0.62, corrected <italic>P </italic>= 0.536)</bold>
Funnel plots of rs12255372 polymorphism studies for T homozygotes vs. G homozygotes (corrected z = 0.62, corrected P = 0.536).
###end p 58
###begin p 59
###xml 95 97 95 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink">z </italic>
###xml 115 117 115 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 0 125 0 125 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Funnel plots of rs12255372 polymorphism studies for heterozygotes vs. G homozygotes (corrected <italic>z </italic>= 0.77, corrected <italic>P </italic>= 0.442)</bold>
Funnel plots of rs12255372 polymorphism studies for heterozygotes vs. G homozygotes (corrected z = 0.77, corrected P = 0.442).
###end p 59
###begin p 60
###xml 94 101 94 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 0 140 0 140 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Cumulative meta-analysis of the odds ratios of association between rs12255372 polymorphism of <italic>TCF7L2 </italic>gene and T2DM for T allele vs. H allele</bold>
Cumulative meta-analysis of the odds ratios of association between rs12255372 polymorphism of TCF7L2 gene and T2DM for T allele vs. H allele.
###end p 60
###begin p 61
###xml 94 101 94 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 0 150 0 150 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Cumulative meta-analysis of the odds ratios of association between rs12255372 polymorphism of <italic>TCF7L2 </italic>gene and T2DM for T homozygotes vs. G homozygotes</bold>
Cumulative meta-analysis of the odds ratios of association between rs12255372 polymorphism of TCF7L2 gene and T2DM for T homozygotes vs. G homozygotes.
###end p 61
###begin p 62
###xml 94 101 94 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 0 150 0 150 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Cumulative meta-analysis of the odds ratios of association between rs12255372 polymorphism of <italic>TCF7L2 </italic>gene and T2DM for heterozygotes vs. G homozygotes</bold>
Cumulative meta-analysis of the odds ratios of association between rs12255372 polymorphism of TCF7L2 gene and T2DM for heterozygotes vs. G homozygotes.
###end p 62
###begin title 63
Allele comparisons
###end title 63
###begin p 64
###xml 38 45 38 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 87 89 87 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CI</italic>
###xml 194 196 194 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CI</italic>
###xml 243 245 243 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CI</italic>
###xml 286 288 286 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CI</italic>
###xml 329 331 329 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CI</italic>
###xml 429 436 429 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 628 630 628 630 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 630 634 630 634 <sub xmlns:xlink="http://www.w3.org/1999/xlink">TvG </sub>
###xml 647 649 647 649 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CI</italic>
###xml 724 726 724 726 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 791 793 791 793 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Q </italic>
###xml 803 805 803 805 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 814 815 814 815 <italic xmlns:xlink="http://www.w3.org/1999/xlink">I</italic>
###xml 815 817 815 817 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 852 853 852 853 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 863 865 863 865 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F16">16</xref>
###xml 586 593 <span type="species:ncbi:9606">persons</span>
The frequency of the risk allele T at TCF7L2 gene among controls was 18.0 percent (95% CI: 13.5, 22.5) and was considerable variation in different ethnic populations (for Caucasians, 27.9% (95% CI: 27.0, 28.9); for North Europeans, 22.3% (95% CI: 12.6, 32.1); for East Asians, 2.1 (95% CI: 1.4, 2.7); and for Indians, 23.1% (95% CI: 17.8, 28.3)). We first contained all the 29 studies to evaluate the overall association between TCF7L2 IVS4G>T polymorphism and T2DM. With our allele-based analysis, the summary odds ratio suggested a 1.379-fold increase in susceptibility to T2DM among persons with the T allele (random-effects ORTvG = 1.379, 95% CI: 1.307, 1.454), with a finding that was highly statistically significant (P = 0.000), but there was significant between-study heterogeneity (Q = 66.191, P = 0.000; I2 = 57.7%) (Table 6 [Additional file 1], figure 16).
###end p 64
###begin p 65
###xml 62 69 62 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 0 108 0 108 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Odds ratios of association between rs12255372 polymorphism of <italic>TCF7L2 </italic>gene and T2DM for T allele vs. H allele</bold>
Odds ratios of association between rs12255372 polymorphism of TCF7L2 gene and T2DM for T allele vs. H allele.
###end p 65
###begin title 66
Genotype comparisons
###end title 66
###begin p 67
###xml 26 33 26 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 131 132 131 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 173 175 173 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 175 176 175 176 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 196 198 196 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 198 199 198 199 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 532 534 532 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 534 536 534 536 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 575 578 575 578 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CrI</italic>
###xml 656 658 656 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 658 660 658 660 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4 </sub>
###xml 680 683 680 683 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CrI</italic>
###xml 766 768 766 768 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Q </italic>
###xml 778 780 778 780 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 789 790 789 790 <italic xmlns:xlink="http://www.w3.org/1999/xlink">I</italic>
###xml 790 792 790 792 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 808 810 808 810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F17">17</xref>
###xml 831 833 831 833 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Q </italic>
###xml 843 845 843 845 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 854 855 854 855 <italic xmlns:xlink="http://www.w3.org/1999/xlink">I</italic>
###xml 855 857 855 857 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 873 875 873 875 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F18">18</xref>
###xml 919 921 914 916 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 943 946 938 941 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CrI</italic>
The genotype frequency of TCF7L2 IVS4G>T polymorphism between case and control groups is characterized in Table 4, Additional file 1. The genotype effects for TT versus GG (OR3) and TG versus GG (OR4) were calculated for each study (data are not shown and available from the first author on request). In our primary concern, multivariate meta-analysis was conducted to estimate the pooled effects and there was an significant increased risk of T2DM among populations with both homozygous variant TT genotype (Bayesian random-effect OR2 = 1.885, 95 percent credible interval (CrI): 1.698, 2.088) and heterozygous variant TG genotype (Bayesian random-effect OR4 = 1.360, 95 percent CrI: 1.291, 1.433), with a "moderate" between-study heterogeneity both in the former (Q = 46.515, P = 0.015, I2 = 39.8%, figure 17) and in the latter (Q = 47.980, P = 0.011, I2 = 41.6%, figure 18). The estimated stochastic parameter lambda2 was 0.486 (95 percent CrI: 0.431, 0.545), which suggested a codominant genetic mode of action.
###end p 67
###begin p 68
###xml 62 69 62 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 0 118 0 118 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Odds ratios of association between rs12255372 polymorphism of <italic>TCF7L2 </italic>gene and T2DM for T homozygotes vs. G homozygotes</bold>
Odds ratios of association between rs12255372 polymorphism of TCF7L2 gene and T2DM for T homozygotes vs. G homozygotes.
###end p 68
###begin p 69
###xml 62 69 62 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 0 118 0 118 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Odds ratios of association between rs12255372 polymorphism of <italic>TCF7L2 </italic>gene and T2DM for heterozygotes vs. G homozygotes</bold>
Odds ratios of association between rs12255372 polymorphism of TCF7L2 gene and T2DM for heterozygotes vs. G homozygotes.
###end p 69
###begin title 70
Examination of heterogeneity
###end title 70
###begin p 71
###xml 144 146 144 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 146 148 146 148 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 165 167 162 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 182 184 179 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 184 186 181 183 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4 </sub>
###xml 203 205 197 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 596 598 590 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 598 600 592 594 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 604 606 598 600 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 606 607 600 601 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 692 693 686 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 886 888 880 882 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 888 890 882 884 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 891 893 885 887 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Q </italic>
###xml 902 904 896 898 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 913 914 907 908 <italic xmlns:xlink="http://www.w3.org/1999/xlink">I</italic>
###xml 914 916 908 910 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 929 931 923 925 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 931 933 925 927 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4 </sub>
###xml 934 936 928 930 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Q </italic>
###xml 945 947 939 941 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 956 957 950 951 <italic xmlns:xlink="http://www.w3.org/1999/xlink">I</italic>
###xml 957 959 951 953 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 993 994 987 988 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 1124 1126 1118 1120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 1126 1128 1120 1122 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 1329 1332 1323 1326 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CrI</italic>
###xml 1370 1372 1364 1366 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 1372 1374 1366 1368 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 1386 1389 1380 1383 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CrI</italic>
###xml 1417 1420 1411 1414 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CrI</italic>
###xml 1447 1450 1441 1444 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CrI</italic>
###xml 1480 1483 1474 1477 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CrI</italic>
###xml 1529 1531 1523 1525 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 1531 1533 1525 1527 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4 </sub>
###xml 1569 1572 1563 1566 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CrI</italic>
###xml 1615 1618 1609 1612 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CrI</italic>
###xml 1656 1658 1650 1652 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 1658 1660 1652 1654 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4 </sub>
###xml 1672 1675 1666 1669 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CrI</italic>
###xml 1718 1721 1712 1715 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CrI</italic>
###xml 1772 1775 1766 1769 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CrI</italic>
###xml 1829 1830 1823 1824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 1863 1865 1852 1854 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 1909 1912 1898 1901 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CrI</italic>
###xml 1963 1966 1952 1955 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CrI</italic>
###xml 2013 2016 2002 2005 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CrI</italic>
###xml 2075 2078 2064 2067 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CrI</italic>
###xml 2138 2140 2122 2124 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 2160 2163 2144 2147 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CrI</italic>
Meta-regression was used to explore the source of heterogeneity and it was found that ethnicity was the only co-variable associated with both lnOR3 (beta = -0.1083, P = 0.005) and lnOR4 (beta = -0.0418, P = 0.047). We then did a subgroup analysis by stratifying study samples into five racial descent groups, that is, Caucasians (9 samples), North European (4 samples), East Asian (8 samples), Indians (4 samples) and other racial descent group (4 samples), and found that this stratification can remove all the between-study heterogeneity among North Europeans, East Asians and Indians for both OR3 and OR4, rather than that among Caucasians and other ethnic group (Table 6, Additional file 1). We then extracted the studies with other Caucasians (7 studies) for an independent analysis, and found that such analysis can well-done remove the heterogeneity among these studies for both OR3 (Q = 8.407, P = 0.210, I2 = 28.6%) and OR4 (Q = 4.327, P = 0.633, I2 = 0.0%) (Table 6, Additional file 1). We did not do a further analysis of other ethnic group because of different origin of populations in these studies. The pooled OR3 for four ethnic groups (data of other ethnic group not shown for the heterogeneity of these studies) by descending ranking, that is, Caucasians, North Europeans, East Asians and Indians, was 2.091 (95%CrI: 1.755, 2.528; for other Caucasians, OR3 = 1.860 (95%CrI: 1.672, 2.012)), 1.889 (95%CrI: 1.485, 2.412), 1.875 (95%CrI: 0.464~3.439), and 1.593 (95%CrI: 1.286, 2.086), respectively, and the pooled OR4 by descending ranking was 1.569 (95%CrI: 1.304, 1.887) for East Asians, 1.413 (95%CrI: 1.299, 1.555; for other Caucasians, OR4 = 1.326 (95%CrI: 1.251, 1.412)) for Caucasians, 1.380 (95%CrI: 1.222, 1.569) for North Europeans, and 1.358 (95%CrI: 1.176, 1.579) for Indians (Table 6, Additional file 1). The estimated parameter lambda2 by descending ranking was 0.744 (95 percent CrI: 0.341, 1.996) for East Asians, 0.657 (95 percent CrI: 0.403, 0.982) for Indians, 0.507 (95 percent CrI: 0.347, 0.748) for North Europeans, and 0.470 (95 percent CrI: 0.410, 0.534) for Caucasians (for other Caucasians, lambda2 = 0.455, 95 percent CrI: 0.376, 0.541), which suggested codominant genetic mode of action among all these four ethnic populations.
###end p 71
###begin p 72
###xml 44 46 44 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 46 48 46 48 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 54 56 54 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 56 58 56 58 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4 </sub>
###xml 190 192 190 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 192 193 192 193 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 211 213 208 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 228 230 225 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 230 231 227 228 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 249 251 243 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 326 333 320 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 510 512 504 506 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 512 514 506 508 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 515 517 509 511 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Q </italic>
###xml 527 529 521 523 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 538 539 532 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink">I</italic>
###xml 539 541 533 535 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 556 558 550 552 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 558 560 552 554 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4 </sub>
###xml 561 563 555 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Q </italic>
###xml 573 575 567 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 584 585 578 579 <italic xmlns:xlink="http://www.w3.org/1999/xlink">I</italic>
###xml 585 587 579 581 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 608 610 602 604 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 610 611 604 605 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 613 615 607 609 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 615 616 609 610 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 628 630 617 619 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 677 680 666 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CrI</italic>
###xml 707 710 696 699 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CrI</italic>
###xml 741 744 730 733 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CrI</italic>
###xml 786 788 775 777 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 788 789 777 778 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 791 793 780 782 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 793 794 782 783 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 806 808 790 792 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 857 860 841 844 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CrI</italic>
###xml 887 890 871 874 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CrI</italic>
###xml 921 924 905 908 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CrI</italic>
###xml 1095 1097 1079 1081 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 1097 1099 1081 1083 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 1100 1102 1084 1086 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1117 1119 1101 1103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 1119 1121 1103 1105 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 1122 1124 1106 1108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
Although BMI was not associated with both lnOR3 and lnOR4 by separate meta-regression analysis, the significant association was found when we evaluate it together with racial descent (for lnOR3, beta = -0.0600, P = 0.029; for lnOR4, beta = -0.0467, P = 0.000). In addition, some references reported that BMI may interact with TCF7L2 gene to increase the risk of T2MD. Therefore, we also did a subgroup analysis for BMI in this polymorphism. However, such stratification can remove few heterogeneity for both lnOR3 (Q = 22.517, P = 0.084, I2 = 37.2%) and lnOR4 (Q = 19.733, P = 0.042, I2 = 47.0%). The pooled OR3, OR4, and lambda2 for populations with normal BMI were 1.795 (95%CrI: 1.480, 2.211), 1.397 (95%CrI: 1.254, 1.567), and 0.572 (95%CrI: 0.448, 0.731), respectively. The pooled OR3, OR4, and lambda2 for populations with abnormal BMI were 1.957 (95%CrI: 1.710, 2.210), 1.343 (95%CrI: 1.261, 1.429), and 0.442 (95%CrI: 0.377, 0.511), respectively. Logistic regression analysis indicated that there was no significant difference between populations with normal and abnormal BMI for both lnOR1 (P = 0.069) and lnOR2 (P = 0.152).
###end p 72
###begin title 73
Other polymorphisms
###end title 73
###begin p 74
###xml 128 130 128 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 130 134 130 134 <sub xmlns:xlink="http://www.w3.org/1999/xlink">CvT </sub>
###xml 147 149 147 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CI</italic>
###xml 165 167 165 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 176 178 176 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Q </italic>
###xml 188 190 188 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 199 200 199 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink">I</italic>
###xml 200 202 200 202 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 351 353 351 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 353 357 353 357 <sub xmlns:xlink="http://www.w3.org/1999/xlink">CvG </sub>
###xml 377 379 377 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CI</italic>
###xml 395 397 395 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 406 408 406 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Q </italic>
###xml 418 420 418 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 429 430 429 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink">I</italic>
###xml 430 432 430 432 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 514 515 514 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 529 531 529 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 531 532 531 532 <sub xmlns:xlink="http://www.w3.org/1999/xlink">5</sub>
###xml 534 536 534 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 536 537 536 537 <sub xmlns:xlink="http://www.w3.org/1999/xlink">6</sub>
###xml 549 551 544 546 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 591 594 586 589 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CrI</italic>
###xml 621 624 616 619 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CrI</italic>
###xml 655 658 650 653 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CrI</italic>
###xml 700 702 695 697 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 702 703 697 698 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 705 707 700 702 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 707 708 702 703 <sub xmlns:xlink="http://www.w3.org/1999/xlink">8</sub>
###xml 720 722 710 712 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4 </sub>
###xml 762 765 752 755 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CrI</italic>
###xml 792 795 782 785 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CrI</italic>
###xml 825 828 815 818 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CrI</italic>
###xml 1066 1068 1056 1058 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 1068 1069 1058 1059 <sub xmlns:xlink="http://www.w3.org/1999/xlink">5</sub>
###xml 1081 1083 1071 1073 <italic xmlns:xlink="http://www.w3.org/1999/xlink">z </italic>
###xml 1101 1103 1091 1093 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1116 1118 1106 1108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 1118 1119 1108 1109 <sub xmlns:xlink="http://www.w3.org/1999/xlink">6</sub>
###xml 1131 1133 1121 1123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">z </italic>
###xml 1151 1153 1141 1143 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1188 1190 1178 1180 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 1190 1191 1180 1181 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 1203 1205 1193 1195 <italic xmlns:xlink="http://www.w3.org/1999/xlink">z </italic>
###xml 1223 1225 1213 1215 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1238 1240 1228 1230 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 1240 1241 1230 1231 <sub xmlns:xlink="http://www.w3.org/1999/xlink">8</sub>
###xml 1253 1255 1243 1245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">z </italic>
###xml 1273 1275 1263 1265 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 61 73 <span type="species:ncbi:9606">participants</span>
###xml 283 295 <span type="species:ncbi:9606">participants</span>
The C allele of IVS3T>C polymorphism (10 studies with 15,718 participants (8,175 cases of T2DM, 7,543 controls); random-effects ORCvT = 1.323, 95% CI: 1.232, 1.419, P = 0.000; Q = 12.615, P = 0.181, I2 = 28.7 percent) and the C allele of IVS4G>C polymorphism (15 studies with 21,161 participants (11,260 cases of T2DM, 9,901 controls); random-effects ORCvG = 1.238, 95 percent CI: 1.153, 1.330, P = 0.000; Q = 20.968, P = 0.102, I2 = 33.2 percent) were significantly associated with T2DM (Table 6, Additional file 1). The pooled OR5, OR6, and lambda3 for IVS3T>C polymorphism were 1.771 (95%CrI: 1.525, 2.062), 1.292 (95%CrI: 1.199, 1.402), and 0.450 (95%CrI: 0.330, 0.598), respectively. The pooled OR7, OR8, and lambda4 for IVS4G>C polymorphism were 1.471 (95%CrI: 1.300, 1.706), 1.242 (95%CrI: 1.152, 1.355), and 0.561(95%CrI: 0.393, 0.777), respectively. These all suggested a codominant genetic mode of action among such two polymorphisms. We did not find any evidence of small sample bias and publication bias for any of the studies (IVS3T>C polymorphism: for OR5, corrected z = 0.54, corrected P = 0.592; for OR6, corrected z = 1.43, corrected P = 0.152; IVS4G>C polymorphism: for OR7, corrected z = 0.40, corrected P = 0.692, for OR8, corrected z = 1.39, corrected P = 0.166), and cumulative meta-analysis results for both allele-based and genotype-based analysis of the above two polymorphisms were stable (data and figure are not shown and available from the first author on request).
###end p 74
###begin title 75
Discussion
###end title 75
###begin title 76
Main findings
###end title 76
###begin p 77
###xml 341 348 341 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 731 738 731 738 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 201 213 <span type="species:ncbi:9606">participants</span>
This is a large meta-analysis, including data from 25 papers involved in 36 genetic association studies with exactly 35,843 cases of T2DM and 39,123 controls, carefully avoiding the double-counting of participants in the study. The HuGE systematic review provides the most recent and comprehensive evaluation of the association between four TCF7L2 gene polymorphisms and susceptibility to T2DM. We find that near 70,000 subjects (33,135 cases of T2DM and 36,316 controls) were from 35 studies concerning the IVS3C>T polymorphism, and over 55,000 (28,188 cases of T2DM and 29,047 controls) subjects were from 29 studies investigating the IVS4G>T polymorphism. These two variants were the main study focus on the association between TCF7L2 gene polymorphisms and susceptibility to T2DM.
###end p 77
###begin p 78
###xml 73 80 73 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 1492 1494 1492 1494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B57">57</xref>
###xml 1495 1497 1495 1497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B71">71</xref>
###xml 1568 1570 1568 1570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B61">61</xref>
###xml 1571 1573 1571 1573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B62">62</xref>
###xml 1574 1576 1574 1576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B82">82</xref>
###xml 2127 2134 2127 2134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
On one hand, the results indicates notable associations between two main TCF7L2 gene polymorphisms, namely, IVS3C>T as well as IVS4G>T, and T2DM. The magnitudes of this association were moderate, however, statistically significant. Our primary analysis finds that among IVS3C>T polymorphism, TC heterozygotes carry just over a 1.4-fold increased risk of T2MD, and TT homozygous variants carry near a 2.0-fold increase in T2MD risk when compared with CC homozygotes, and that among IVS4G>T polymorphism, TG heterozygotes carry near a 1.4-fold increased risk of T2MD, and TT homozygous variants carry approximate a 1.9-fold increase in T2MD risk when compared with GG homozygotes. Significant magnitudes of genetic effect for heterozygotes of these two variants were confirmed by the analysis on the pooled odds ratios among different ethnic groups with slight differences except for East Asians where higher pooled odds ratio was observed in IVS4G>T polymorphism when compared with that of the other ethnic populations, and genetic effect sizes for homozygotes of these two variants were also strengthened by the analysis on the pooled odds ratios among different ethnic groups including Caucasians, North Europeans, Africans and Indians by showing a small variation. However, we found that there was no significant association between such two homozygotes and disease among East Asians, and therefore, conflicting results have appeared, in which studies on Chinese provided negative results [57,71], however, positive results were observed among Japanese populations [61,62,82]. Our meta-analysis on 9 studies of IVS3C>T polymorphism and 7 studies of IVS4G>T polymorphism among East Asians indicates a moderate statistical association and shows that the heterozygous variants contributed all the increased risk of T2MD among this population. This distinct disparity may suggest different mechanism of gene-disease between East Asians and other ethnic population. Moreover, although less samples and subjects were provided, the IVS3T>C and IVS4G>C polymorphisms are also significantly associated with T2DM. We then suggest that TCF7L2 is the most common susceptible gene for T2DM among various ethnic groups in the world.
###end p 78
###begin p 79
###xml 244 246 239 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CI</italic>
###xml 269 276 264 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 850 857 845 852 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
On the other hand, we made no assumptions about genetic models and finds that the pooled odds ratios can clearly fit a multiplicative model and the lambda (lambda) parameter can well-done indicate a codominant genetic mode of action with tight CIs among all these four TCF7L2 gene polymorphisms. We also explored the genetic mode among different ethnic populations and similar results were observed in Caucasians, North Europeans, East Asians and Indians except for Africans, where dominant genetic mode is suggested for IVS3C>T polymorphism. We cannot verify the genetic mode of action for Africans in the other three polymorphisms due to few studies. In addition, genetic mode of IVS3C>T variant among Africans also need a further verification by more studies. Even so, we nevertheless suggest a potential multiplicative genetic model for the four TCF7L2 gene polymorphisms.
###end p 79
###begin p 80
###xml 146 153 146 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 189 191 189 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B77">77</xref>
###xml 282 284 282 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B73">73</xref>
###xml 285 287 285 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B74">74</xref>
###xml 288 290 288 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B76">76</xref>
###xml 356 358 356 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B55">55</xref>
###xml 359 361 359 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B57">57</xref>
###xml 362 364 362 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B71">71</xref>
###xml 365 367 365 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B88">88</xref>
###xml 769 776 769 776 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
The effect size of overall association between IVS3C>T variant and T2MD is near to 1.42, which is lower than that in a former meta-analysis about TCF7L2 and T2MD performed by Cauchi et al [77], and larger than that in a pooled analysis of three genome-wide association (GWA) study [73,74,76]. we supplement some studies about East Asians and Pima Indians [55,57,71,88] in which risk homozygous variant TT was scanty, and excluded several studies without genotype frequency data, which may decrease the overall effect but provide a more comprehensive understanding of the association. Even so, we cannot find any significant difference of effect size between our study with the former meta-analysis as well as the pooled GWA studies. In addition, we computed the PAR of TCF7L2 according to IVS3C>T variant and the PAR for the combined genotypes TT and TC were 16.9, 23.2, 14.1, 2.5, 17.9, 27.0 for overall, Caucasians, North Europeans, East Asians, Indians, and Africans, respectively, suggesting this gene polymorphism may contribute near 1/5 of all T2MD in the globe except for East Asians.
###end p 80
###begin p 81
###xml 817 819 817 819 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 819 821 819 821 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 825 827 825 827 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 827 828 827 828 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 857 859 857 859 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 859 861 859 861 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 865 867 865 867 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 867 868 867 868 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 1109 1111 1109 1111 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 1366 1368 1366 1368 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 1368 1370 1368 1370 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 1373 1375 1373 1375 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 1375 1376 1375 1376 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 1460 1467 1460 1467 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 1596 1598 1596 1598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B59">59</xref>
###xml 1618 1620 1618 1620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B62">62</xref>
###xml 1643 1645 1643 1645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B67">67</xref>
###xml 1718 1719 1718 1719 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 1745 1747 1745 1747 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 1752 1754 1752 1754 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RR</italic>
###xml 1831 1833 1831 1833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B82">82</xref>
###xml 1850 1852 1850 1852 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B70">70</xref>
###xml 1875 1878 1875 1878 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B104">104</xref>
###xml 2406 2413 2406 2413 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 2565 2572 2565 2572 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 2797 2799 2797 2799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B56">56</xref>
###xml 2800 2802 2800 2802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B63">63</xref>
###xml 2803 2805 2803 2805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B68">68</xref>
###xml 2806 2808 2806 2808 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B71">71</xref>
###xml 2809 2812 2809 2812 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B105">105</xref>
###xml 2829 2831 2829 2831 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B63">63</xref>
###xml 2832 2834 2832 2834 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B68">68</xref>
###xml 2835 2837 2835 2837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B71">71</xref>
###xml 2838 2841 2838 2841 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B105">105</xref>
###xml 2850 2853 2850 2853 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B106">106</xref>
###xml 2869 2871 2869 2871 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B64">64</xref>
###xml 2872 2874 2872 2874 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B69">69</xref>
###xml 2892 2894 2892 2894 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B64">64</xref>
###xml 2895 2897 2895 2897 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B69">69</xref>
###xml 2898 2901 2898 2901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B105">105</xref>
###xml 2931 2938 2931 2938 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 79 91 <span type="species:ncbi:9606">participants</span>
###xml 879 884 <span type="species:ncbi:9606">Human</span>
Our findings were based on some gene-association studies and tens of thousands participants and were robust to each of the planned sensitivity analyses used. We cannot find any evidence of publication bias and small study bias by funnel plots and cumulative meta-analysis, but, considerable between-study heterogeneity was found. Between-study heterogeneity may be due to differences in sample selection (e.g., in age, sex, diagnosis, sample content, etc), or in methods (e.g., genotyping method), or it may be due to real differences in populations (e.g., in race), or in interactions with other risk factors (genetic or/and environmental factors). The results of primary analysis (genotype-based) on the four polymorphisms showed statistically significant between-study heterogeneity for both IVS3C>T polymorphism (OR1 and OR2), and IVS4G>C polymorphism (OR3 and OR4). In this Human Genome Epidemiology review, we examined five potential sources of between-study heterogeneity for genotype-based model by meta-regression and it was suggested that ethnicity was the only co-variable associated with the four ORs. In fact, more detailed manner of ethnic stratification, namely, French Caucasians, other Caucasians, North Europeans, East Asians, Indians, and Africans, can remove near all the heterogeneity of studies about both IVS3C>T and IVS4G>C polymorphisms for OR1 to OR4. Study results reported by several articles showed that BMI may cooperate with the TCF7L2 gene to increase the risk of the T2DM. However, disagreement of the results was published by different researchers. Cauchi et al[59], Horikoshi et al [62] and Humphries et al [67] separated to analyze the nonobese type 2 diabetic subjects (BMI<30 Kg/m2) and more higher allelic ORs or RRs were obtained in IVS3C>T and IVS4G>C polymorphisms; whereas, Miyake et al [82], Chandak et al[70], and Dahlgren et al [104] found that there was a slight increase or no change of odds ratio by adjustment of BMI. So we stratified the studied by BMI (normal vs. abnormal) and found that significant between-study heterogeneity nevertheless appeared in all the two subgroups. Both studies on IVS3C>T and IVS4G>C polymorphisms provided us for the similar results. But, we found a significant association when it was evaluated together with ethnicity. These results, on the one hand, suggested that BMI may be a possible factor to impact on the effect of TCF7L2 gene on T2DM by a indirect action; on the other hand, were difficult for us to explain the deep-seated reasons that how the BMI influence the effect of TCF7L2 gene on T2DM because we cannot gain the original data of BMI in each article. This is a general limitation of meta-analysis. So we hope the reasonable interpretation will be presented in the subsequent studies. Although sex [56,63,68,71,105], age of cases [63,68,71,105], drugs[106], constitution[64,69], and lifestyle [64,69,105] may regulate the effects of TCF7L2 gene, we cannot test the effects of age, sex, drugs and lifestyle on heterogeneity due to without sufficient related data being used. In addition, the age of the control NGT groups may be associated with the heterogeneity and the young controls may develop diabetes at a later date. However, there are also insufficient data.
###end p 81
###begin title 82
Potential gene-gene and gene-environment interaction
###end title 82
###begin p 83
T2DM seems to result from a complicated interplay of genetic and environmental factors influencing a number of intermediate traits of relevance to the diabetic phenotype (e.g., insulin secretion, insulin action, fat distribution, obesity). As a matter of fact, T2DM appears to be composed of subtypes where genetic susceptibility is strongly associated with environmental factors at one end of the spectrum, and highly genetic forms at the other end. Thus, there are several possible interactions between gene and gene or between gene and environmental factors.
###end p 83
###begin p 84
###xml 141 143 141 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B73">73</xref>
###xml 144 146 144 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B76">76</xref>
###xml 147 150 147 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B107">107</xref>
###xml 331 333 331 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 333 336 333 336 <sub xmlns:xlink="http://www.w3.org/1999/xlink">TvC</sub>
###xml 403 409 391 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2</italic>
###xml 465 467 453 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 507 511 495 499 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HHEX</italic>
###xml 513 516 501 504 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IDE</italic>
###xml 518 523 506 511 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DKK3 </italic>
###xml 527 532 515 520 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KIF11</italic>
###xml 579 582 567 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B108">108</xref>
###xml 583 586 571 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B113">113</xref>
###xml 620 627 608 615 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 662 664 650 652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B59">59</xref>
###xml 694 701 682 689 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 836 843 824 831 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 847 858 835 846 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Calpain-10 </italic>
###xml 884 887 872 875 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B114">114</xref>
###xml 1149 1156 1131 1138 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 1184 1187 1163 1166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B115">115</xref>
###xml 1267 1274 1246 1253 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 1458 1465 1437 1444 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
Recent years, a series of new loci in some genes have been identified to contribute about 10~30% population attributable risk (PAR) of T2DM [73-76,107]. But, the overall PAR seems to far less than the cumulative effect. So there must be some potential interactions among genes. The strongest known T2DM association (random-effects ORTvCapproximately1.42) was recently mapped to the transcription factor TCF7L2, a gene that is a target of the Wnt signaling pathway [50]. Whereafter, some other genes such as HHEX, IDE, DKK3 and KIF11, which are also in the Wnt signaling pathway [108-113] may have some interactions with TCF7L2 on the risk of T2DM. Cauchi et al [59]found that the expression of TCF7L2 gene was downregulated in obese subjects developing T2DM and they then brought forward a hypothesis of a potential interaction between TCF7L2 and Calpain-10 by a supporting material [114] that suggested that the Calpain system was involved in the constitutive regulation of beta-catenin signaling functions. Wnt signaling has recently been shown to regulate pancreatic beta-cell proliferation and the author suggested a possible interation between TCF7L2 gene and beta-catenin gene [115]. However, there is not any reported publication about the interaction between TCF7L2 other related genes. These hypothetical interactions and their specific effects on T2DM, as well as functional analyses, will be required to further elucidate the role of variation in TCF7L2 in the pathogenesis of T2MD and very large samples are needed.
###end p 84
###begin p 85
###xml 212 215 212 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B116">116</xref>
###xml 276 283 276 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 382 389 382 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 759 762 759 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B117">117</xref>
###xml 871 873 871 873 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B67">67</xref>
###xml 986 989 986 989 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B118">118</xref>
###xml 1064 1066 1064 1066 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 1122 1126 1122 1126 <sub xmlns:xlink="http://www.w3.org/1999/xlink">T2D </sub>
###xml 1272 1275 1272 1275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B106">106</xref>
###xml 1606 1608 1606 1608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B67">67</xref>
###xml 1695 1702 1695 1702 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 2086 2089 2086 2089 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B116">116</xref>
###xml 2280 2287 2280 2287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 477 485 <span type="species:ncbi:9606">patients</span>
A variety of environmental factors can be implicated in the phenotype of T2DM, such as obesity, hypertension, bad lifestyle (smoking, drinking, high-energy diet), short of exercise, malnutrition, and some drugs [116]. All the above environmental factors may interact with the TCF7L2 gene to influence T2DM. So far, few specific gene-environment interactions have been described for TCF7L2 gene polymorphisms. Because obesity is a major determinant of development of T2DM, most patients with T2DM are obese when they develop diabetes, and obesity aggravates the insulin resistance. BMI and waist circumstance may become the main focus on attention of interactions, particularly in studies of IVS3C>T and IVS4G>C polymorphism among T2DM. Cauchi and colleagues [117] reported that IVS3C>T risk allele is more prevalent in non-obese than in obese diabetics. Humphries et al [67] found a statistically significant interaction between IVS3C>T as well as IVS4G>C genotype and BMI. Wang et al [118] replicated the result of Humphries et al. In succession, Helgason et al [47] discovered that two haplotypes, that is, HapA and HapBT2D had a interaction with BMI, and that the former was associated with increased BMI, whereas the latter was associated decreased BMI. Florez et al [106], observed that another index of obesity, waist circumstance, showed a nominally significant interation with both IVS3C>T and IVS4G>T in spite of no interaction between BMI and genotype. In addition, plasma triglyceride (TG) and C-reactive protein (CRP) have also been found to interact with genotype of both IVS3C>T and IVS4G>T [67]. These early findings suggestive of gene-environment interactions with the different TCF7L2 gene polymorphisms should be interpreted extremely cautiously, however, and much larger and more detailed studies are looked forward to substantiating such putative interactions with appropriate power and rigor. Complementarily, Smoking and drinking were important risk factors to influence on T2DM and they can also interact with genetic factor to increase the risk of this disease [116]. We found a higher proportion of current or/and past smokers and drinkers in the study populations. But, it was regretted for us that there was no any report about the interactions between TCF7L2 gene polymorphisms and smoking or/and drinking in all the open publications. This is a meaningful and valuable domain to explore.
###end p 85
###begin title 86
Limitation of this meta-analysis
###end title 86
###begin p 87
###xml 1052 1059 1052 1059 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
The lack of information especially the genotype data from some articles was the main limitation, we have done our possible to contact exhaustibly to the authors of publication that did not provide the original data and obtained full data on about 75 percent of subjects involved in various ethnic populations. Next, the quality of diagnosis, match, and genotyping varied a lot among studies, but the summary results were not changed when these questions were discussed carefully. There was considerable heterogeneity in IVS3C>T and IVS4G>T polymorphisms in our initial results. However, we discovered the main sources of the heterogeneity and were able to remove it finally. A question we cannot resolve is that how the four snps discussed here in strong LD will lead to differences in T2DM association among diverse populations. Besides, since environment factors and genes, such as obesity, smoking, drinking, and hypertension as well as plasma TG, and gene related to the Wnt signaling pathway are strong candidates for a potential interaction with TCF7L2 gene polymorphisms, the lack of data available to us on most of those environmental factors (except for obesity) and genes was a limitation, which we hope will be demonstrated by the following studies.
###end p 87
###begin title 88
Conclusions and recommendation for future researches
###end title 88
###begin p 89
###xml 83 90 83 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 278 285 278 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 481 488 481 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 778 785 778 785 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
This large meta-analysis summarizes the strong evidence for an association between TCF7L2 gene and T2DM both overall and in Caucasians, North Europeans, East Asians, Indians, and Africans, and suggested a potential multiplicative genetic model for all the four polymorphisms of TCF7L2 gene among different ethnic populations except for Africans, where additive genetic mode is suggested for IVS3C>T polymorphism. Our study results also suggest that IVS3C>T and IVS4G>T variants of TCF7L2 gene can be taken as reference loci for exploring T2DM susceptibility. We found and removed the main source of heterogeneity; however, we cannot find any evidence of bias. Furthermore, we estimated the potential gene-gene and gene-environmental interactions by which common variants in the TCF7L2 gene influence risk of T2DM. These two domains are just the recommendation for future researches.
###end p 89
###begin title 90
Abbreviations
###end title 90
###begin p 91
###xml 6 11 <span type="species:ncbi:9606">Human</span>
HuGE: Human Genome Epidemiology; T2DM: type 2 diabetes mellitus; TCF7L2: Transcription factor 7-like 2; CI: confidence interval; CrI: credible interval; OR: odds ratio; NGT: normal glucose tolerant; BMI: body mass index; HWE: Hardy-Weinberg equilibrium.
###end p 91
###begin title 92
Competing interests
###end title 92
###begin p 93
The authors declare that they have no competing interests.
###end p 93
###begin title 94
Authors' contributions
###end title 94
###begin p 95
BZ, YT, YL, and YZ carried out the design of this meta-analysis, analyzed the data and drafted the manuscript. YZ and JYY conducted a searching, data extraction, and statistical analysis on the manuscript. YWZ performed a searching and data extraction on the manuscript. HCL participated in designing and writing for the manuscript. All authors read and approved the final manuscript.
###end p 95
###begin title 96
Pre-publication history
###end title 96
###begin p 97
The pre-publication history for this paper can be accessed here:
###end p 97
###begin p 98

###end p 98
###begin title 99
Supplementary Material
###end title 99
###begin title 100
Additional file 1
###end title 100
###begin p 101
###xml 0 28 0 28 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Title: Tables. Tables 1 &#8211; 6.</bold>
Title: Tables. Tables 1 - 6.
###end p 101
###begin p 102
Click here for file
###end p 102
###begin title 103
Acknowledgements
###end title 103
###begin p 104
This work was partially supported by grants from China's National Natural Science Foundation (contact No. 30771219) and the Science Research Foundation of Chinese Ministry of Health (contact No. WKJ2007-3-001).
###end p 104
###begin p 105
The authors thank Dr. Huaigong Chen for checking coding of some of the data. They also thank the authors who kindly provided genotype and allele frequency data for the meta-analyses.
###end p 105
###begin article-title 106
Diagnosis and classification of diabetes mellitus
###end article-title 106
###begin article-title 107
Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes
###end article-title 107
###begin article-title 108
Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections
###end article-title 108
###begin article-title 109
Global and societal implications of the diabetes epidemic
###end article-title 109
###begin article-title 110
Prevalence of diabetes in rural and urban populations in southern Sierra Leone: a preliminary survey
###end article-title 110
###begin article-title 111
A prevalence survey of diabetes in Mauritania
###end article-title 111
###begin article-title 112
A population-based study of the prevalence of diabetes and impaired glucose tolerance in adults in northern Sudan
###end article-title 112
###begin article-title 113
Prevalence of adult diabetes in Ibadan, Nigeria
###end article-title 113
###begin article-title 114
Increasing prevalence of Type 2 diabetes mellitus in all ethnic groups in Mauritius
###end article-title 114
###begin article-title 115
Nationwide prevalence study of hypertension and related non-communicable diseases in The Gambia
###end article-title 115
###begin article-title 116
[Prevalence of type 2 diabetes mellitus and glucose intolerance in the Setif area (Algeria)]
###end article-title 116
###begin article-title 117
Diabetes and impaired fasting glycemia in the tribes of Khagrachari hill tracts of Bangladesh
###end article-title 117
###begin article-title 118
Epidemiologic study of type 2 diabetes in Taiwan
###end article-title 118
###begin article-title 119
Type 2 diabetes in rural and urban population: diverse prevalence and associated risk factors in Bangladesh
###end article-title 119
###begin article-title 120
Prevalence of non-insulin dependent diabetes mellitus in urban areas of eastern Nepal: a hospital based study
###end article-title 120
###begin article-title 121
Prevalence of diabetes and impaired fasting glucose in Korea: Korean National Health and Nutrition Survey 2001
###end article-title 121
###begin article-title 122
Prevalence of diabetes mellitus in Japan compiled from literature
###end article-title 122
###begin article-title 123
The changing demography of diabetes mellitus in Singapore
###end article-title 123
###begin article-title 124
Rising prevalence of NIDDM in an urban population in India
###end article-title 124
###begin article-title 125
Diabetes and impaired glucose tolerance. A prevalence estimate based on the Busselton 1981 survey
###end article-title 125
###begin article-title 126
Prevalence and incidence of diabetes in a Swedish community 1972-1987
###end article-title 126
###begin article-title 127
[Prevention of diabetes mellitus type 2]
###end article-title 127
###begin article-title 128
[Prevalence of diabetes mellitus and glucose intolerance in the population aged 30 to 75 years in Asturias, Spain]
###end article-title 128
###begin article-title 129
###xml 77 82 <span type="species:ncbi:9606">women</span>
Prevalence of diabetes and impaired glucose tolerance in 64-year-old Swedish women: experiences of using repeated oral glucose tolerance tests
###end article-title 129
###begin article-title 130
[Epidemiology, management and costs of type 2 diabetes in France in 1998]
###end article-title 130
###begin article-title 131
[Prevalence of diabetes, antidiabetic treatment and chronic diabetic complications reported by general practitioners]
###end article-title 131
###begin article-title 132
Prevalence of NIDDM and impaired glucose tolerance in Italy: an OGTT-based population study
###end article-title 132
###begin article-title 133
Evidence of an increasing prevalence of diagnosed diabetes mellitus in the Poole area from 1983 to 1996
###end article-title 133
###begin article-title 134
Prevalences of diabetes and impaired glucose regulation in a Danish population: the Inter99 study
###end article-title 134
###begin article-title 135
Prevalence of type 2 diabetes and impaired fasting glucose in the middle-aged population of three French regions - The MONICA study 1995-97
###end article-title 135
###begin article-title 136
[Diabetes mellitus incidence and its prevalence in Moscow]
###end article-title 136
###begin article-title 137
[Diabetes in Italy: a public health problem]
###end article-title 137
###begin article-title 138
Non-insulin-dependent diabetes in Kuwait: prevalence rates and associated risk factors
###end article-title 138
###begin article-title 139
Type II Diabetes Mellitus and impaired glucose tolerance in Yemen: prevalence, associated metabolic changes and risk factors
###end article-title 139
###begin article-title 140
Prevalence of glucose intolerance in urban and rural communities in Saudi Arabia
###end article-title 140
###begin article-title 141
Type 2 diabetes mellitus, impaired glucose tolerance and associated factors in a rural Palestinian village
###end article-title 141
###begin article-title 142
###xml 40 48 <span type="species:ncbi:9606">children</span>
Incidence and prevalence of diabetes in children aged 0-14 years in Manitoba, Canada, 1985-1993
###end article-title 142
###begin article-title 143
Tribal differences in diabetes: prevalence among American Indians in New Mexico
###end article-title 143
###begin article-title 144
[Prevalence of non insulin dependent diabetes mellitus and associated risk factors in the Mazatec population of the State of Oaxaca, Mexico]
###end article-title 144
###begin article-title 145
Multicenter study of the prevalence of diabetes mellitus and impaired glucose tolerance in the urban Brazilian population aged 30-69 yr. The Brazilian Cooperative Group on the Study of Diabetes Prevalence
###end article-title 145
###begin article-title 146
Prevalence of type 2 diabetes and obesity in rural Mapuche population from Chile
###end article-title 146
###begin article-title 147
Prevalence of diabetes mellitus and impaired glucose tolerance in the urban population aged 30-69 years in Ribeirao Preto (Sao Paulo), Brazil
###end article-title 147
###begin article-title 148
[Prevalence of type 2 diabetes and obesity in two Chilean aboriginal populations living in urban zones]
###end article-title 148
###begin article-title 149
High prevalence of diabetes and impaired glucose tolerance in India: National Urban Diabetes Survey
###end article-title 149
###begin article-title 150
[Study on the epidemiological characteristics of diabetes mellitus and IGT in China]
###end article-title 150
###begin article-title 151
###xml 41 46 <span type="species:ncbi:9606">human</span>
Assignment of the TCF-4 gene (TCF7L2) to human chromosome band 10q25.3
###end article-title 151
###begin article-title 152
Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution
###end article-title 152
###begin article-title 153
Attenuated Wnt signaling perturbs pancreatic growth but not pancreatic function
###end article-title 153
###begin article-title 154
Wnt signaling: physiology and pathology
###end article-title 154
###begin article-title 155
TCF-4 mediates cell type-specific regulation of proglucagon gene expression by beta-catenin and glycogen synthase kinase-3beta
###end article-title 155
###begin article-title 156
Convergence of Wnt, beta-catenin, and cadherin pathways
###end article-title 156
###begin article-title 157
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human T-cell transcription factor-4 gene: structure, extensive characterization of alternative splicings, and mutational analysis in colorectal cancer cell lines
###end article-title 157
###begin article-title 158
Variants of the transcription factor 7-like 2 (TCF7L2) gene are associated with type 2 diabetes in an African-American population enriched for nephropathy
###end article-title 158
###begin article-title 159
Common single nucleotide polymorphisms in TCF7L2 are reproducibly associated with type 2 diabetes and reduce the insulin response to glucose in nondiabetic individuals
###end article-title 159
###begin article-title 160
TCF7L2 is not a major susceptibility gene for type 2 diabetes in Pima Indians: analysis of 3,501 individuals
###end article-title 160
###begin article-title 161
###xml 112 117 <span type="species:ncbi:9606">women</span>
###xml 122 125 <span type="species:ncbi:9606">men</span>
Variant of transcription factor 7-like 2 (TCF7L2) gene and the risk of type 2 diabetes in large cohorts of U.S. women and men
###end article-title 161
###begin article-title 162
Replication and identification of novel variants at TCF7L2 associated with type 2 diabetes in Hong Kong Chinese
###end article-title 162
###begin article-title 163
Association of transcription factor 7-like 2 (TCF7L2) variants with type 2 diabetes in a Finnish sample
###end article-title 163
###begin article-title 164
###xml 82 87 <span type="species:ncbi:9606">human</span>
Transcription factor TCF7L2 genetic study in the French population: expression in human beta-cells and adipose tissue and strong association with type 2 diabetes
###end article-title 164
###begin article-title 165
Association analysis of 6,736 U.K. subjects provides replication and confirms TCF7L2 as a type 2 diabetes susceptibility gene with a substantial effect on individual risk
###end article-title 165
###begin article-title 166
Replication study for the association of TCF7L2 with susceptibility to type 2 diabetes in a Japanese population
###end article-title 166
###begin article-title 167
A genetic variation of the transcription factor 7-like 2 gene is associated with risk of type 2 diabetes in the Japanese population
###end article-title 167
###begin article-title 168
TCF7L2 in the Go-DARTS study: evidence for a gene dose effect on both diabetes susceptibility and control of glucose levels
###end article-title 168
###begin article-title 169
Variants of the transcription factor 7-like 2 gene (TCF7L2) are strongly associated with type 2 diabetes but not with the metabolic syndrome in the MONICA/KORA surveys
###end article-title 169
###begin article-title 170
TCF7L2 polymorphisms are associated with type 2 diabetes in northern Sweden
###end article-title 170
###begin article-title 171
Association of variants of transcription factor 7-like 2 (TCF7L2) with susceptibility to type 2 diabetes in the Dutch Breda cohort
###end article-title 171
###begin article-title 172
###xml 129 132 <span type="species:ncbi:9606">men</span>
###xml 137 142 <span type="species:ncbi:9606">women</span>
Common variants in the TCF7L2 gene and predisposition to type 2 diabetes in UK European Whites, Indian Asians and Afro-Caribbean men and women
###end article-title 172
###begin article-title 173
Association of TCF7L2 polymorphisms with type 2 diabetes in Mexico City
###end article-title 173
###begin article-title 174
The rs12255372(G/T) and rs7903146(C/T) polymorphisms of the TCF7L2 gene are associated with type 2 diabetes mellitus in Asian Indians
###end article-title 174
###begin article-title 175
Common variants in the TCF7L2 gene are strongly associated with type 2 diabetes mellitus in the Indian population
###end article-title 175
###begin article-title 176
Association study of the genetic polymorphisms of the transcription factor 7-like 2 (TCF7L2) gene and type 2 diabetes in the Chinese population
###end article-title 176
###begin article-title 177
Genetics of type 2 diabetes
###end article-title 177
###begin article-title 178
Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels
###end article-title 178
###begin article-title 179
A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants
###end article-title 179
###begin article-title 180
A genome-wide association study identifies novel risk loci for type 2 diabetes
###end article-title 180
###begin article-title 181
Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes
###end article-title 181
###begin article-title 182
TCF7L2 is reproducibly associated with type 2 diabetes in various ethnic groups: a global meta-analysis
###end article-title 182
###begin article-title 183
The new type 2 diabetes gene TCF7L2
###end article-title 183
###begin article-title 184
A new era in finding Type 2 diabetes genes-the unusual suspects
###end article-title 184
###begin article-title 185
The importance of TCF7L2
###end article-title 185
###begin article-title 186
The transcription factor 7-like 2 (TCF7L2) gene is associated with Type 2 diabetes in UK community-based cases, but the risk allele frequency is reduced compared with UK cases selected for genetic studies
###end article-title 186
###begin article-title 187
Association of TCF7L2 polymorphisms with susceptibility to type 2 diabetes in 4,087 Japanese subjects
###end article-title 187
###begin article-title 188
Common variants of the TCF7L2 gene are associated with increased risk of type 2 diabetes mellitus in a UK-resident South Asian population
###end article-title 188
###begin article-title 189
Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group
###end article-title 189
###begin article-title 190
Statistical aspects of the analysis of data from retrospective studies of disease
###end article-title 190
###begin article-title 191
Meta-analysis in clinical trials
###end article-title 191
###begin article-title 192
Bayesian random effects meta-analysis of trials with binary outcomes: methods for the absolute risk difference and relative risk scales
###end article-title 192
###begin article-title 193
Bayesian implementation of a genetic model-free approach to the meta-analysis of genetic association studies
###end article-title 193
###begin article-title 194
A comparison of tests for Hardy-Weinberg equilibrium
###end article-title 194
###begin article-title 195
Impact of violations and deviations in Hardy-Weinberg equilibrium on postulated gene-disease associations
###end article-title 195
###begin article-title 196
A disequilibrium coefficient approach to Hardy-Weinberg testing
###end article-title 196
###begin article-title 197
Quantitative synthesis in systematic reviews
###end article-title 197
###begin article-title 198
Meta-analysis in Stata
###end article-title 198
###begin article-title 199
Measuring inconsistency in meta-analyses
###end article-title 199
###begin article-title 200
Quantifying heterogeneity in a meta-analysis
###end article-title 200
###begin article-title 201
Why sources of heterogeneity in meta-analysis should be investigated
###end article-title 201
###begin article-title 202
Explaining heterogeneity in meta-analysis: a comparison of methods
###end article-title 202
###begin article-title 203
Investigating underlying risk as a source of heterogeneity in meta-analysis
###end article-title 203
###begin article-title 204
Obstacles and opportunities in meta-analysis of genetic association studies
###end article-title 204
###begin article-title 205
Bias in meta-analysis detected by a simple, graphical test
###end article-title 205
###begin article-title 206
Cumulative meta-analysis of therapeutic trials for myocardial infarction
###end article-title 206
###begin article-title 207
###xml 166 169 <span type="species:ncbi:9606">men</span>
Variants of the TCF7L2 gene are associated with beta cell dysfunction and confer an increased risk of type 2 diabetes mellitus in the ULSAM cohort of Swedish elderly men
###end article-title 207
###begin article-title 208
###xml 118 130 <span type="species:ncbi:9606">participants</span>
Transcription factor 7-like 2 polymorphisms and type 2 diabetes, glucose homeostasis traits and gene expression in US participants of European and African descent
###end article-title 208
###begin article-title 209
TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program
###end article-title 209
###begin article-title 210
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
###end article-title 210
###begin article-title 211
Hex homeobox gene-dependent tissue positioning is required for organogenesis of the ventral pancreas
###end article-title 211
###begin article-title 212
Hex homeobox gene controls the transition of the endoderm to a pseudostratified, cell emergent epithelium for liver bud development
###end article-title 212
###begin article-title 213
Heart induction by Wnt antagonists depends on the homeodomain transcription factor Hex
###end article-title 213
###begin article-title 214
Association and haplotype analysis of the insulin-degrading enzyme (IDE) gene, a strong positional and biological candidate for type 2 diabetes susceptibility
###end article-title 214
###begin article-title 215
###xml 90 93 <span type="species:ncbi:9606">men</span>
Polymorphisms in the insulin-degrading enzyme gene are associated with type 2 diabetes in men from the NHLBI Framingham Heart Study
###end article-title 215
###begin article-title 216
###xml 130 136 <span type="species:ncbi:9606">people</span>
High-density haplotype structure and association testing of the insulin-degrading enzyme (IDE) gene with type 2 diabetes in 4,206 people
###end article-title 216
###begin article-title 217
The calpain system is involved in the constitutive regulation of beta-catenin signaling functions
###end article-title 217
###begin article-title 218
Wnt signaling regulates pancreatic beta cell proliferation
###end article-title 218
###begin article-title 219
Epidemiology of Diabetes Mellitus
###end article-title 219
###begin article-title 220
Effects of TCF7L2 polymorphisms on obesity in European populations
###end article-title 220
###begin article-title 221
Variants of transcription factor 7-like 2 (TCF7L2) gene predict conversion to type 2 diabetes in the Finnish Diabetes Prevention Study and are associated with impaired glucose regulation and impaired insulin secretion
###end article-title 221

